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the promptly attained levels of GARAMYCIN achieved in the urine are considerably higher
than the concentrations required for effectiveness against virtually all susceptible gram
negative pathogens. GARAMYCIN is excreted through the kidney in unchanged form by
glomerular filtration. It is especially successful in the treatment of urinary tract infections,
such as acute and chronic pyelonephritis, cystitis, urethritis, and prostatitis.

Dramatic Results in a Broad Range of Systemic Infections.7 ’0

Dramatic results have
been reported in the treatment of severe systemic infections, respiratory infections,
bacteremia, wounds and burns complicated by sepsis. In cases of severe infections compli
cated by septicemia (with and without shock), GARAMYCIN may be lifesaving.

Quick Onset o f Action — Long Duration of E ffec t.’ Clinical studies show that GARAMYCIN
Injection provides peak bactericidal serum concentrations within about one hour following
recommended I.M. dosage and that effective serum levels are maintained for 6 to 8 hours.
1M inim al Risk o f Side Effects.2' *■ 9adverse side effects is remarkably low.
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QUILL ON SCALPEL

This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

ARE T-TUBES REALLY NECESSARY?
In “Quill on Scalpel” in the July 1971
issue, J. C. Osborne described three pa
tients who had developed bile peritonitis
after removal of T-tubes from the common
bile duct. His experience has prompted
the question in my title and these com
ments.
The question implies two other questions:
(1) should a common bile duct be drained
after it is explored, and (2) if drained,
should it be by a T-tube? I do not intend
to discuss the first question. Most surgeons
agree that, after exploration, the duct
should be drained, both as a precaution
against temporary obstruction at the am
pulla of Vater and to provide an oppor
tunity for a postoperative cholangiogram.
But, why a T-tube? Certain advantages
seem obvious. A free passage for bile is
provided, and the cross-bar of the T gives
some stability in the duct. If circumstances
make it necessary, the tube can be left in
place for a long time. There was a time
when surgeons believed that splinting a
healing wound in a duct assisted healing;
most now accept that a foreign body in
contact delays healing.
Against these possible advantages, there
are some disadvantages. In the days when
it was part of my job to remove T-tubes,
I was always horrified by what I thought
I was doing to that fragile but vital duct.
Pulling the tube out often required a sur
prising amount of force. One could picture
the duct, perhaps somewhat unsupported
after the operative dissection, containing a
little sutured incision and, at 10 or 12 days,
in one of the weakest stages of healing;
then the pull comes on, the tube stretches,
the cross-bar buckles and, suddenly, the
tube tears its way out of the duct.
More and more over the years, surgeons
have come to realize that adequate drain

age can be provided by a small calibre
tube and various maneuvers have been
used to make extraction less violent: the
arms have been cut short, a notch has been
cut opposite the stem, or the cross-bar has
been sliced open. Even so, the fact remains
that to emerge, the cross-bar must buckle,
and requires a hole at least twice as large
as the one occupied by the stem. Some
violence must be done, but in the great
majority of patients we get away with it.
There is an alternative. One of my old
chiefs, the late Norman Shenstone, did not
like T-tubes. He also appreciated that a
very small tube could provide sufficient
drainage. After the exploration he intro
duced a straight tube, which was distinctly
smaller than the duct, with an open end
directed towards the liver, and extending
about one inch beyond the edge of the in
cision. The defect in the wall was repaired
and, as the last stitch was placed, a stabi
lizing loop was passed around the tube and
tied. Suitable slack was allowed and a
further stitch fastened the tube to the skin.
A postoperative cholangiogram could be
done in the usual way. When the time
came to remove the tube, it could easily
be slipped out all the way, or just enough
to free it from the duct, and then left for
a further day or two as a precaution
against leakage.
Having used this technique many times
myself, I can attest that it is both simple
and satisfactory.
F. G. K erc.in
KNEE-LIGAMENT IN JU RIES
With the current emphasis on fitness and
athletic activity, an increasing number of
“week-end athletes” are engaging in sports
such as skiing, snowmobiling, rugger,
soccer and touch football, each of which
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carries a significant risk of knee injury.
Add these usually ill-conditioned amateurs
to the large numbers of well-conditioned
athletes in organized sport who are ex
posed to violent trauma, and it is no sur
prise that the incidence of major disrup
tions of knee ligaments is increasing at an
alarming rate.
Despite the fact that knee-ligament in
juries are now commonplace, physicians
and surgeons know surprisingly little about
their diagnosis and treatment, and in many
undergraduate and postgraduate institu
tions teaching concerning the recognition
and management of these acute injuries is
inadequate. Most of the current literature
is devoted to a variety of methods of re
pair for chronically unstable knees and the
large number of patients described in some
of these series suggests that the recognition
or initial treatment of the acute injury was
unsatisfactory.
While reviewing major knee-ligament
injuries in the Wellesley Hospital, Toronto,
the most striking finding was that the
seriousness of the problem was unrecog
nized by the initial examiner in virtually
every case. Invariably radiographs were
made but these do not reveal the extent
of the soft-tissue trauma.
Is it important to recognize a serious
knee-ligament disruption? The amount of

Fig. 1.—Laxity of the medial collateral liga
ment eight weeks after a severe rugger injury.
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Fig. 2.—Laxity of the lateral collateral ligament
eight months after the patient was struck by a
car.

instability shown in two knees, eight weeks
(Fig. I ) and eight months (Fig. 2) after
injury, illustrates that these ligaments do
not heal themselves effectively without
adequate initial treatment. I would empha
size that such errors in diagnosis are not
confined to small emergency departments
or country hospitals. The patient whose
knee is shown in Fig. 3 was sent home
from our emergency department with un
recognized tears of the following struc
tures: lateral collateral ligaments, postero
lateral joint capsule, popliteus tendon, ilio
tibial band, biceps femoris tendon, lateral
meniscus and both the anterior and
posterior cruciate ligaments! Fortunately,
he was reassessed 10 days later by a knowl
edgeable medical student. The seriousness
of his injury was recognized, the structures
were repaired and a good stable knee re
sulted. There should be no doubt, how
ever, that inadequate initial treatment leads
to a poor result which, at best, may limit
an athlete’s performance and, at worst, may
finish his career and produce permanent
disability.
How is a serious knee injury recognized?
As in any medical or surgical condition,
by taking an adequate history. If the pa-
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Fig. 3.—Marked instability of the lateral side
of the knee 10 days after a rugger injury.

tient has significant trauma and is unable
to continue his activity, be highly sus
picious of a major ligament disruption.
Physical examination may be misleading,
because muscle spasm may mask gross in
stability. If the history is one of immedi
ate disability and the physical examination
equivocal, examine the patient under gen
eral anesthesia and obtain a stress radio
graph of the knee; only in this way can
you assess the injury accurately. An
arthrogram, which may be combined with
this examination, gives further information
about the type of ligament tear and the
state of the menisci.
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Is a serious knee injury best treated
by operative repair or plaster immobiliza
tion? There are many vociferous propon
ents of both approaches. My experience
suggests that pure collateral-ligament tears
treated for eight weeks in a long-leg
plaster with the knee flexed at 90° heal
with minimal residual laxity. On the other
hand, treatment in a simple plaster cylinder
with the knee extended seldom restores
stability to a severely injured knee. If bony
fragments are avulsed or cruciate liga
ments torn, careful operative repair ap
pears to give the best results.
Can an athlete continue to perform on
an unstable knee after acute injury and
have a repair at the end of the season?
This approach fnay be advocated by
coaches, managers and avid sports fans,
but it is not in the athlete’s best interests.
The time to deal with a major knee-liga
ment injury is when it occurs; delayed
repair will never give as satisfactory a re
sult as proper initial treatment.
What is desperately needed is a set of
guidelines to determine what is, indeed,
the best treatment of an acutely injured
knee. A controlled objective measurement
of laxity at the time of injury followed by
an identical assessment at regular inter
vals up to three years after treatment is
essential to establish such guidelines. Hope
fully, this will place the diagnosis and
treatment of knee-ligament injuries on the
firm scientific basis expected of twentieth
century medicine.
D. E. H
a s t in g s

The Wellesley Hospital,
Toronto, Ont.
This editorial is based on an address given at the
Grey Cup Symposium, Canadian Academy of
Sports Medicine, Toronto, Ont., November 27,
1970.
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R E V I E W ARTICLES
TH E GASTROINTESTINAL HORMONES
JOHN DUPRE, M.A., M.R.C.P., M ontreal, Que.

known that the pancreas affects carbo
hydrate metabolism by producing a hypo
glycemic agent, and some speculated that
this function might also be controlled by
an intestinal hormone. Evidence was ob
tained of the existence of such an agent8
and it was named “incretin”. However,
interest in this question waned when other
workers could not confirm the findings
upon which the conclusion was based, 9 and
found evidence that blood glucose levels
could regulate pancreatic endocrine func
tion.10’ 11
Until recently, progress in the study of
gastrointestinal hormones was hampered
by the impurity of preparations derived
from extracts of intestinal mucosa. More
over, the classical techniques of extirpation
and replacement treatment, used to study
the physiology of the discrete endocrine
glands, could not be applied readily to
these problems. Nevertheless all accepted
the physiologic importance of an array of
intestinal hormones which might co-oper
ate with the nervous system in regulating
digestive function. Recent studies using
protein chemistry and radioimmunoassays
for peptide hormones have answered some
of these questions and have posed new
ones. With the preparation of highly puri
fied or synthetic hormones, further exam
ination of the pharmacology of these agents
has revealed the remarkably wide and
overlapping ranges of their actions. Several
workers have used assays capable of
estimating peptide hormones in biologic
fluids to examine their functions more
directly. Others have searched for the ana
tomical sources of these hormones using
optical and electron microscopy. As a re
sult we can now investigate a number of
disease states which involve abnormalities
of humoral secretions of the intestine. This
review will describe briefly the chemistry,
pharmacology, and physiology of the
identified gastrointestinal hormones. It will
“Associate Professor, Department of Medicine,
McGill University; Director, Fraser Laboratory
also examine evidence concerning the ana
for Research in Diabetes, Royal Victoria Hospital,
tomical sources of these hormones, consider
Montreal, Que.

R e c e n t advances in protein chemistry and

in assays for peptide hormones have
yielded much new information on the en
docrinology of the gastrointestinal tract.
Some of the findings do not fit easily into
classical descriptions of the physiology of
gastrointestinal hormones. Because much
of this new knowledge will shed light on
common disease processes, it is useful to
review the subject and to consider its
possible applications to clinical medicine.
The gastrointestinal hormones were
identified during the search for the physio
logic stimuli that regulate the exocrine
secretions of the gut. The well-character
ized members of the group were recog
nized as activities in extracts of gastro
intestinal mucosa: secretin as a stimulus
to increased output of bicarbonate-rich
pancreatic exocrine secretion, 1 gastrin as a
stimulus to gastric-acid secretion , 2 ’ 3 and
pancreozymin as a stimulus to pancreatic
enzyme secretion .4 Although the nervous
system may modify both the release and
the effects of these agents, they can prob
ably act independently of the nervous
system, because in each case their endo
genous release leads to the expected re
sponse even in denervated target glands.5
Analogous mechanisms stimulate gall
bladder contraction when fat enters the
small intestine, 6 and inhibit gastric-acid
secretion when acid enters the small in
testine; 7 the names cholecystokinin and
enterogastrone have been given to these
putative hormones. In the expectation that
a specific humoral agent would be found
to regulate each of the exocrine secretions,
the control of production of duodenal and
small intestinal succus entericus was at
tributed to hormones dubbed “duocrinin”
and “enterocrinin”. In addition, when
secretin was discovered it was already
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studies of their pathophysiology in human
disease, and interpret observations based
on classical and modern techniques, show
ing that both are necessary in this field.
T he C h e m istr y an d P h a r m a co lo g y
of Secretin , G astrin , and
Pa n c r e o zy m in

Secretin
Secretin is assayed in terms of its
capacity to stimulate secretion of bicarbon
ate-rich pancreatic secretion. This activity
was isolated from extracts of porcine duo
denojejunal mucosa:12 its structure has
been
determined
and
its
synthesis
achieved.13’ 14 Secretin contains 27 amino
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Structurally, secretin and glucagon are
similar: 14 of the amino-acid residues o c 
cur at corresponding loci in each (Table
I ). These similarities may underlie the
effects that the two hormones have in
common, such as their insulinotrophic21’ 28
and choleretic actions,16’ 27 and may also
explain their ability to inhibit each other;
e.g. glucagon depresses secretin-stimulated
exocrine secretion.28

Gastrin
The gastrins were the first gastroin
testinal hormones to be identified structur
ally and the first to be synthesized. Tw o
gastrins, assayed in terms of their ability
to stimulate gastric-acid secretion, were

TABLE I.— S t r u c t u r a l S i m il a r i t i e s

of

S e c r e t in and G l u c a g o n *

Secretin

His. Ser. Asp. Gly. Thr. Phe. Thr. Ser. Glu. Leu. Ser. Arg. Leu. Arg. Asp.
Ser. Ala. Arg. Leu. Gin. Arg. Leu. Leu. Gin. Gly. Leu. Val.-■n h 2

Glucagon

His. Ser. Gin. Gly. Thr. Phe. Thr. Ser. Asp. Tyr. Ser. Lys. Tyr. Leu. Asp.
Ser. Arg. Arg. Ala. Gin. Asp. Phe. Val. Gin. Try. Leu. Met, Asn. Thr.

‘ Fourteen loci with corresponding residues are underlined.

acids in an open chain. When the biologic
activity of synthetic partial secretin pep
tides was examined, no potent subunit was
identified, and even the hexacosapeptide
(2-27) showed very little activity.15 In
addition to its actions on pancreatic exo
crine function, secretin stimulates produc
tion of bile and increases bicarbonate out
put by the liver.18 In the dog, it also stimu
lates the secretion of pepsin17 and of duo
denal succus entericus.18 Gastrin-stimulated
gastric-acid secretion is inhibited in the
dog19 and in man.20 In addition to these
effects on external secretions, exogenous
secretin stimulates the release of insulin
from the pancreas in man and in the
dog.21’ 22 This hormone also has a lipolytic
effect on adipose tissue in vitro.23 Secretin
can inhibit gastric motility,24 and can in
crease pancreatic blood flow.25 All these
experiments were done with porcine secre
tin and, while there is considerable varia
tion in the sensitivity of different species
to the several effects of the hormone, we
have no information as yet concerning
possible species variation of the hormone
itself.

isolated from extracts of porcine pyloric
mucosa29 and two analogous peptides were
later derived from human antral mucosa.30
The agents prepared in this way, heptadecapeptide amides, occur in each species
in two forms, which differ only in that they
are non-sulfated or sulfated at the tyrosyl
residue adjacent to the C-terminal pentapeptide; these variants are designated
gastrin I and gastrin II respectively. The
biologic activities of gastrins I and II are
closely similar. A variety of abbreviated
synthetic analogues retain the biologic
activity of the total peptide, which resides
in the C-terminal tetrapeptide and is
virtually abolished when the terminal
amide group is removed.31 A synthetic
pentapeptide with gastrin activity has been
used widely in pharmacologic and clinical
studies.32
In addition to stimulating gastric-acid
secretion, gastrin evokes secretion of pep
sin33 and intrinsic factor34 by the stomach.
It has a weak secretin-like effect and a
powerful pancreozymin-like effect on the
exocrine pancreas.35 The outflow of bile is
stimulated.30 Administration of the hor-
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mone can increase the rhythmic motor
activity of the stomach33 but may also
delay gastric emptying.37 In some species,
but not in man, high doses of gastrin in
hibit gastric-acid secretion.38 With regard
to possible effects of gastrin on pancreatic
endocrine function, the evidence is con
flicting; intravenous injection of bolus doses
of gastrin may stimulate secretion of in
sulin in vivo,22 but an insulinotrophic effect
is not demonstrable in vitro 39 Gastrin may
act as a direct humoral stimulus to release
secretin,40 a finding that must be taken
into account when interpreting the effect
of exogenous gastrin on pancreatic func
tion in vivo.

mones, the two activities kept company,
and we now know that both reside in the
same peptide.45 In several recent accounts,
this hormone has been called pancreozymin-cholecystokinin but, in this review,
it will be referred to as “pancreozymin” .
As isolated from porcine duodenojejunal
mucosa, pancreozymin is a single-chain
peptide with 33 amino-acid residues
(Table II). The C-terminal pentapeptide
is identical with that of the gastrins, and
the adjacent residue is tyrosyl, sulfated as
in gastrin II.48 Studies with various partial
peptides showed that, on a molar basis, the
C-terminal octapeptide with a sulfated
tyrosyl residue has cholecystokinin activity

T A B L E I I .— G a s t r i n , P a n c r e o z y m in - C h o l e c y s t o k in in , a n d C a e r u l e i n *

Human gastrin II

Glu.
Gly.

Gly.
Try.

Pro. Try.
Met. Asp.

Caerulein

Glu.

Gin.

Asp.

Porcine
panereozymincholecystokinin

Lys.

Leu. Glu(5).
Phe-NH2

Tyr.(Sn3H)

(Ala1, G ly2, Pro1, Ser2)
(Asx1, G lx1, His1, Leu2,
Asp. T yr.(So3H) Met. Gly.

*Octapeptide (single-underlined)
gastrin activity.

Thr.

Ala.

Gly.

Tyr. (So,H)

Try.

Met.

Asp.

Phe-NH2

Arg.Val. (Isoleu1,
M et1, Ser1) Lys. Asp.
Pro1, Ser2) Arg. Isoleu. Ser. Asp. Arg.
Try.
Met. Asp.Phe-NIL

has cholecystokinin activity;

pentapeptide (double-underlined) has

greater than that of the total peptide, and
the corresponding non-sulfated octapeptide
has greatly diminished cholecystokinetic
activity.47 However, since the sulfated and
non-sulfated gastrins do not differ in their
cholecystokinin potency, it is apparent that
this biologic activity is not simply related
to the presence or absence of sulfate at the
tyrosyl residue.
In addition to its effects on pancreatic
enzyme secretion and its cholecystokinetic
action, pancreozymin can stimulate gastricacid secretion in some species,48 and can
stimulate secretion of duodenal succus
entericus.49 Pancreozymin can also act as
a competitive inhibitor of gastrin-stimu
Pancreozymin
lated gastric-acid secretion.50 The hormone
Pancreozymin, recognized and assayed inhibits gastric motility but increases duo
as a stimulus to the external secretion of denal motility and relaxes the sphincter of
pancreatic enzymes, was isolated from ex Oddi.45 Exogenous pancreozymin is a
tracts of porcine duodenojejunal mucosa.44 potent stimulus to insulin secretion in
Cholecystokinin, assayed in terms of man51 and in the dog,22 and can stimulate
stimulation of contraction of gallbladder glucagon secretion in the dog22 and prob
muscle, was present in similar extracts. In ably in man.51 As we know with secretin,
the progressive purification of these hor- there are species variations in responses

Before the heptadecapeptide gastrins
were identified, evidence suggested that
biologic gastrin-like activity may be asso
ciated with a molecule that is larger than
these purified peptides.41 Recently, the
immunoassay for gastrin-like materials has
demonstrated a large-molecular-weight immunoreactive gastrin present, in addition
to “small” gastrin, both in the blood42 and
in extracts of gastrointestinal tissues.43
Preliminary evidence suggests that these
two immunoreactive gastrins have similar
biologic activities.43 Thus, the heptadeca
peptide amides may not be the only
physiologically important gastrins.
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to pancreozymin, but there is no informa
tion about possible species variations of
the hormone itself.
Caerulein, another naturally occurring
polypeptide with pharmacologic and struc
tural similarities to pancreozymin and
gastrin, was recently identified in extracts
of the skin of the Australian frog, Hyla
caerulea52 (Table II). This agent, a decapeptide, has powerful pancreozymin and
cholecystokinetic activities; the C-terminal
pentapeptide is identical with that of pan
creozymin and the gastrins, and it has an
adjacent tyrosyl residue. Caerulein stimu
lates gastric-acid secretion in the fasting
state, but can act as a competitive inhibitor
of gastrin-stimulated acid secretion, 53 a
property also exhibited by pancreozymin. 54
These findings have stimulated the search
for synthetic competitive inhibitors of acid
secretion with negligible gastrin-like ac
tivity-agents that might be useful in the
management of clinical conditions associ
ated with gastric hypersecretion.
Concerning the species variations that
have been encountered in the responses to
the pure peptides, Grossman54 suggested
that structural similarities between secre
tin and glucagon, on the one hand, and be
tween the gastrins and pancreozymin, on
the other, may explain synergistic or in
hibitory interactions within each of these
pairs, and that the secretin-like pair and
gastrin-like pair may act at separate re
ceptor sites on target cells. However, there
are interactions between the pairs, which
may be direct or indirect, and it remains
to be seen whether the two-receptor hypo
thesis will stand up to detailed examina
tion. In this context, the pancreatic hor
mone glucagon can be regarded as a
gastrointestinal hormone because ontogenetically the endocrine cells of the pan
creas are related to those of the intestine.
The demonstration of so-called enteroglucagons in intestinal tissues, and of
gastrin-like and secretin-like agents in pan
creatic tumours, which will be considered
later, may further illustrate this relation
ship. Track55 has discussed the evolutionary
significance of these relationships.
Thus, their pharmacologic effects sug
gest that the intestinal hormones so far
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identified might provide the humoral com
ponent of physiologic regulation of gastric,
pancreatic, and duodenojejunal secretions.
Whether this proves to be so must depend
on later descriptions of their actions in
physiologic conditions, and on the dis
covery of the factors that control their
secretion.
S ig n if ic a n c e of R e spo n ses o f T a r g e t
E x o c r in e G lands in S tu d ies o f
E f fe c t s o f H o r m o n e s

Evidence of Endogenous Secretion
of Hormones
The classical descriptions of the control
of secretion of these hormones are largely
based on indirect evidence obtained in
studies of the responses of target glands
in vivo:' Thus, secretion of gastrin can be
inferred from effects on the denervated
fundus, and such evidence suggests that
vagal activity, antral distension, and eleva
tion of gastric mucosal pH evoke release
of the hormone. From the responses of the
target glands, it seems that gastrin secre
tion is inhibited by a feedback mechanism
called into play by acidification of the duo
denal mucosa or by the arrival of certain
nutrients there, and also by a direct in
hibitory action of acid at the antral
mucosa. In the dog, the late intestinal
phase of gastric-acid secretion resists in
hibition by acidification of the antral
mucosa; 88 in this phase, humoral gastrin
like activity may be secreted by the small
intestine. Wang and Grossman57 used the
same approach to study secretin and pan
creozymin secretion. The most powerful
stimulus to secretin release appears to be
acidification of the duodenal mucosa, and
protein hydrolysates appear to be the most
potent stimulus to pancreozymin-like
effects on pancreatic exocrine secretions.
No one has yet identified inhibitory feed
back mechanisms originating in the gut
and affecting the secretion of hormones
that regulate pancreatic exocrine function,
but the interaction of these hormones with
the control mechanisms regulating pancre
atic endocrine function, which will be
described later, may provide such a feed
back. In the case of pancreozymin, this
interaction may be important in interrupt-
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ing the stimulus to continued release of the
hormone, which would be provided by the
delivery of protein in the form of pan
creatic enzymes secreted in response to this
hormone.
Studies of this kind have demonstrated
that a variety of stimuli can produce effects
supposedly due to the identified hormones,
under more or less artificial conditions.
These studies have been designed as far as
possible to isolate the mechanism under
investigation from other possible stimuli.
Evaluation of the multiple potential
stimuli which must be considered in
physiologic conditions, presents a problem
of great complexity. Interactions among
identified stimuli have been studied largely
by examining the effects of exogenous
hormones, administered in various com
binations, sometimes in conjunction with
pharmacologic or surgical interference with
the autonomic nervous system. However,
it is obvious that such experiments cannot
be interpreted unless we know the physio
logically appropriate dosage of the hor
mones.

Effects of Exogenous Hormones
Until recently, in studies with gastro
intestinal hormones it has been necessary
to assume that doses that evoke responses
in the physiologic range are themselves
physiologic. However, this presupposes
that the test agent is equivalent to the
endogenous hormone. Thus, in attempts to
relate effects of an exogenous agent to
those of the endogenous hormone, we can
place greater reliance on the pattern of
effects produced by the test substance than
upon its ability to evoke a selected re
sponse. A lack of correspondence between
these patterns suggests either that the endo
genous hormone in physiologic conditions
exerts effects that depend upon interactions
with other mechanisms or that the native
agent differs from the endogenous one. This
is illustrated by studies of the mechanism
whereby stimulation of the small intestine
inhibits gastric-acid secretion. Delivery of
acid or fat into the small intestine inhibits
acid secretion in man, and this effect is
attributed to the release of enterogastrone.
The same stimuli appear to cause the re
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lease of secretin and pancreozymin, as
judged by their effects on the exocrine
pancreas, and both these hormones can
inhibit gastrin-stimulated gastric-acid secre
tion. The stimuli that evoke the release of
native enterogastrone inhibit both gastrinstimulated and histamine-stimulated acid
secretion, but secretin and pancreozymin
have relatively little effect on the response
to histamine. These and other findings
suggest that physiologic enterogastrone
activity may depend on an agent or agents
not yet identified. The physiologic entero
gastrone may be represented by a peptide
recently isolated from extracts of porcine
duodenojejunal mucosa. This agent is
chemically distinct from secretin and pan
creozymin, and has been shown to inhibit
both histamine and gastrin-stimulated acid
secretion by the canine stomach.58
I n ter a c tio n s B e t w e e n C o ntro l
M e c h a n is m s in t h e R eg u la tio n
of E x o c r in e S e c r e t io n s

Combinations of the known gastro
intestinal hormones show powerful synerg
istic actions under certain conditions; e.g.
the stimulatory effect of secretin on bi
carbonate output by the pancreas can be
greatly potentiated by concurrent admin
istration of pancreozymin.59 Such effects
show that the response of target organs
cannot safely be interpreted in terms of a
single hormonal stimulus. In studies of
humoral regulatory systems, we need a
more direct approach and, at present, this
is offered by assays for the individual hor
mones in the blood. In interpreting the re
sults of such studies, it is important to
take account not only of interactions be
tween hormones but also of the role of
the nervous system. Thus, the autonomic
nervous system may affect the activity of
target glands directly, and also indirectly,
by modifying their sensitivity to humoral
stimuli.

Interactions Between Gastrointestinal
Hormones and the Autonomic Nervous
System in Regulation of Exocrine
Secretions: Gastric Secretions
The response to sham feeding and its
abolition by vagotomy5 suggested a vagally
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mediated cephalic phase of gastric-acid
secretion. This phase is associated with
the release of gastrin, which potentiates
the effect of vagal stimulation on acid
production. Thus, in dogs, subthreshold
doses of gastrin increase acid secretion in
response to feeding after surgical removal
of the gastrin-secreting area of the stom
ach.80 Such observations suggest that a
pathologic increase in acid secretion could
be produced by nervous or humoral mech
anisms or both, or by intrinsic overactivity
of parietal cells. More direct studies of
gastrin secretion by assays for this hor
mone may clarify the picture, but the re
sults of such studies in man are conflict
ing. These observations will be discussed
later in relation to the immunoassay tech
nique and the pathophysiology of peptic
ulceration.
Interactions With the Nervous System:
Pancreatic Secretions
Although vagal stimulation affects pan
creatic secretion, the physiologic import
ance of direct vagal activity and its pos
sible influence on responses to humoral
stimuli have been difficult to assess. Recent
studies in the dog assumed that selective
gastric vagotomy abolished the release of
secretin by preventing gastric-acid secre
tion and it was observed that this pro
cedure did not reduce the volume of pan
creatic secretion during the first 30 minutes
after feeding.61 The authors concluded that
there is an important direct vagal contribu
tion to the early phase of pancreatic secre
tion during a meal. However, although the
volume of pancreatic secretion after feed
ing increased in spite of selective vag
otomy, the pancreatic exocrine response in
terms of bicarbonate output was strikingly
diminished. This suggests that the stimula
tion of bicarbonate production was
abolished when secretin release was pre
vented, while the preservation of an in
creased volume of pancreatic secretion
suggests that this response may be under
nervous control. Electrical stimulation of
the vagus nerve shows that it can exert
direct effects on the pancreas. Stimulation
of the nerve in the dog at an intensity that
by itself has no effect on exocrine secretion
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can make the pancreas respond to sub
threshold doses of secretin or pancreo
zymin.62 Experiments of this kind strongly
suggest that there is an interaction between
the nervous system and the humoral
mechanisms regulating pancreatic exocrine
secretion, and that an intact autonomic
nervous system is necessary for physiologic
responses. However, as in analogous
studies of gastric secretion, these experi
ments cannot distinguish direct effects of
the humoral stimulus on secretion from
effects on the sensitivity of the target
organs to other stimuli.
A ssa y s fo r G a st r o in t e st in a l
H o r m o n e s in t h e B lo o d

It is apparent from the overlapping
pharmacologic effects of purified peptides
derived from the gastrointestinal tract, and
from structural similarities among them,
that we cannot assume specific biologic or
immunologic properties for agents detected
in the blood. However, assays capable of
measuring such activities in blood would
be extremely valuable in studying the
functions of gastrointestinal hormones.
Bioassays
Bioassays for hormones affecting gastro
intestinal exocrine secretions do not con
sistently detect activity in unprocessed
serum or plasma. Circulating gastrin- and
secretin-like activities have been detected
in the blood from patients with tumours
associated with abnormal exocrine secre
tions.66 In spite of defects in sensitivity and
specificity, with further refinement bio
assays may prove increasingly valuable in
the elucidation of clinical syndromes asso
ciated with very high levels of humoral
activity in the blood.
Radioimmunoassays for
Gastrointestinal Hormones
Since Berson and Yallow applied the
principle of competitive binding to the
radioimmunoassay for insulin, analogous
systems have been developed for many
peptide hormones. Antibodies have been
raised to gastrin, secretin, and pancreo
zymin; radioiodinated preparations of
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these hormones have been used as “tracers”
in immunoassay systems. W e can now de
tect agents in the blood that compete with
standard preparations of the hormones for
binding to antibody, and these endogenous
agents have been quantitated in terms of
the purified standards. We must recognize
that antibodies may cross-react with ma
terial other than that used as the antigen.
An assay may detect more than one variant
of the antigenic hormone, as in the case of
insulin and proinsulin; 64 it may detect
degradation products of the hormone, as
in the case of ACTH . 65 Cross-reactions
must depend on structural similarities
among the materials detected and may ex
tend to agents of unknown biologic signifi
cance.
Radioimmunoassays for Gastrin

In these assays, antibodies raised to pre
parations of porcine gastrin of various
degrees of purity, to synthetic human
gastrin, or to pentagastrin, have been used
with iodinated porcine or human gastrins
as tracers. These antisera may cross-react
with pancreozymin, presumably because of
the pentapeptide common to the two hor
mones, but, with selected antisera, the
cross-reaction with pancreozymin may be
sufficiently weak to permit specific estima
tion of gastrin in the presence of physio
logic concentrations of the other hormones.
These assays have been used mainly in
human studies, and here we can discuss
the findings in pathophysiologic states and
those obtained in normal subjects.
Normal subjects and patients with peptic
ulceration have detectable levels of immunoreactive gastrin in the blood after
fasting overnight. Assays using crude por
cine gastrin antiserum, 86 or antipentagastrin serum, 67 have demonstrated fasting
hypergastrinemia in patients with duodenal
ulcers. With these assays, similar patients
showed exaggerated serum gastrin re
sponses after ingestion of protein. How
ever, assays using antibodies to synthetic
human gastrin yielded normal values in
patients with duodenal ulcers. 68 It is pos
sible that these differences arise because
antibodies to mixed gastrins from crude
mucosal extracts or to the common gastrin
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pentapeptide detect a variety of gastrin
like agents,69’ 70 only one of which is
recognized by the synthetic human gastrin
antibody. In studies of the role of the
nervous system in the regulation of gastrin
secretion, there have been discrepancies
among the results obtained with the differ
ent systems. The assay using antiserum to
pentagastrin showed that, in normal sub
jects, atropine inhibits gastrin secretion
after feeding; that fasting gastrin levels are
reduced after vagotomy in patients with
duodenal ulcers; and that gastrin is
elevated during hypoglycemia induced by
insulin. Indeed preliminary studies with
antipentagastrin serum suggest that reduc
tion of fasting gastrin levels after vago
tomy correlates with reduction of gastricacid secretion in response to hypoglycemia,
and that failure of vagotomy to depress the
gastrin response to hypoglycemia may help
the surgeon to recognize those patients
who are liable to recurrent ulceration.
However, these effects of medical or surgi
cal vagotomy and of hypoglycemia on
blood gastrin levels detected with anti
pentagastrin serum were not duplicated
with assays using antisera to synthetic
human gastrin or to crude porcine
gastrin.71 ’ 72 Instead, assays using the
latter two types of antibodies have shown
exaggerated increments of serum gastrin
after ingestion of food, both after admin
istration of atropine and after vagotomy.
In view of the well-known variability of
individual antisera raised to the same anti
gen, the reproducibility of findings with
these three types of antiserum in the
different gastrin immunoassays must be
confirmed. If the reactions are consistent,
the different antisera may be useful in
differentiating the several hypothetical
gastrins. At present, the results with the
antipentagastrin serum suggest that hyper
acidity depends on hypersecretion of
gastrin; this hypersecretion, in turn, may
depend on vagal activity and might indeed
be due to primary vagal overactivity. Even
the maintenance of normal levels of gastrin
in the blood of patients with hyperacidity
suggests inappropriate release of the hor
mone, because its secretion should be in
hibited by the local feedback mechanism. 73
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In attempts to reconcile the conflicting re not be confused. However, although very
sults, the possible importance of humoral high levels of gastrin in the blood have
gastrin-like agents derived from the in characterized the patients with hyper
testine must be considered, especially since acidity associated with gastrin-producing
the intestinal phase of gastric-acid secre tumours so far reported, the differentiation
tion may resist inhibition by acidification of these patients from those with the com
of the antral mucosa, 56 and since there is mon variety of peptic ulcer disease may
evidence that vagal effects on exocrine prove to be less clear cut, as patients with
functions distal to the stomach may resist less classical forms of the Zollinger-Ellison
atropine. In addition, although attention syndrome are investigated. It is important
has been focused on the role of gastrins, also to consider the possibility that high
the conflicting results obtained with assays rates of gastrin secretion might occur in
for this hormone suggest that circulating the absence of gastrin-producing tumours
inhibitors of the effects of gastrin (entero- following interruption of the inhibitory
gastrones) may be equally important in the feedback effect of acid on the antral
physiologic or pathophysiologic control of mucosa as a consequence of previous surgi
cal intervention. In this situation, the sur
acid secretion.
In two well-defined conditions, the re geon could be led to a false diagnosis of
sults of the various immunoassays for the Zollinger-Ellison syndrome. Should this
gastrin have agreed. The great majority of problem arise it would be useful to de
subjects with pernicious anemia have very termine the gastrin content of antral biopsy
high levels of gastrin in the blood in the material, which might be very low in the
fasting state . 7 4 , 75 In some of these indi presence of a gastrin-secreting tumour.
viduals the fasting levels of serum gastrin
have been lower, but such subjects may
Radioimmunoassay for Secretin
have gastritis involving the gastrin-produc
Young, Lazarus and Chisholm 76 have de
ing cells of the antrum. Mean fasting levels
of immunoreactive gastrin rise with in scribed a radioimmunoassay capable of
creasing age, but this trend disappears estimating secretin-like materials in peri
when subjects with impaired acid secre pheral blood from human subjects, and in
tion are eliminated. 76 In subjects with per tests with other gastrointestinal hormones
nicious anemia, acidification of the gastric they demonstrated no cross-reactions. In
mucosa rapidly reduces serum gastrin normal subjects, ingestion of food or
levels. 75 These findings suggest that, in this acidification of the duodenum produced
disease, hypersecretion of gastrin depends the expected elevation of serum secretin
on loss of feedback inhibition as a conse like immunoreactivity, and this immunoquence of failure of the target parietal cells reactivity rose very rapidly after the admin
istration of gastrin. This response probably
to produce acid.
does not depend on the effect of gastrinIn the Zollinger-Ellison syndrome, im
stimulated acid secretion on the release of
munoassays for gastrin-like agents in the
secretin but may reflect a direct secretin
blood also yield abnormally high levels of
releasing action of gastrin itself : 4 0 it was
activity in the fasting state. In these pa
not abolished by aspirating stomach con
tients, tumour extracts contain activity that
tents or by neutralizing gastric acid with
is biologically 77 and immunologically78 in
bicarbonate, and was preserved in one of
distinguishable from synthetic human
two achlorhydric subjects.
gastrin. Elevated immunoreactive gastrin
The chief application of this assay for
in the blood of these patients presumably
secretin has been in studies of the role of
represents autonomous secretion by the
the hormone in response to glucose ad
tumours. Such a finding is valuable diag ministration in man. These studies suggest
nostically: in the great majority of these that secretin is a physiologic regulator of
cases gastrin blood levels fall in a range insulin secretion. Serum secretin-like im
that is otherwise attained only in achlor munoreactivity is substantially, though
hydric subjects, with whom they should briefly, elevated after glucose ingestion , 4 0
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or after infusion of glucose into the small
intestine. 80 The latter finding conflicts with
the classical evidence suggesting that
carbohydrate does not stimulate the re
lease of secretin. 5 7 ' 81 However, in the
classical studies, conditions may not have
favoured a demonstrable exocrine response;
in any case, we cannot assume that release
of secretin in quantities that do not evoke
a pancreatic exocrine response has no
physiologic significance. So far, the most
striking feature of radioimmunoassay
studies of secretin has been the continuous
inverse relationship between serum insulin
and serum secretin in man. In normal man,
insulin seems to exert an inhibitory feed
back effect on the release of secretin: the
elevated fasting serum-secretin levels in
untreated diabetes mellitus, and low
serum-secretin levels after insulin in normal
or diabetic subjects apparently represent
modifications of this feedback. When im
munoassays for secretin are applied to
exocrine aspects of disorders such as de
structive disease of the pancreas, their
interpretation will be complicated by these
endocrine interrelationships. Thus, in dis
orders of metabolism, the concentration of
this hormone in the blood will probably
not be a reliable guide to the functional
capacity of the exocrine pancreas.
Radioimmunoassay for Pancreozymin
Antibodies raised to pancreozymin may
be expected to cross-react with gastrin be
cause the two molecules have a common
pentapeptide, but the reaction between
selected antisera and gastrin may be weak
enough to permit their use in assays for
pancreozymin in the blood. Such an assay
has been used to demonstrate increments
in pancreozymin in blood after the inges
tion of protein or fatty meals, 82 and after
the ingestion of very large doses of glucose.
Since pancreozymin may have a physio- 1
logic role in the regulation of pancreatic
endocrine secretion,22' 83 we shall prob
ably encounter interactions similar to those
described for secretin. These would com
plicate the interpretation of assays for
pancreozymin in studies of diseases of the
exocrine pancreas.
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Radioreceptor Assays
Recently, a number of workers have
studied the binding of radioactive hor
mones to the membranes of target cells.
This approach may lead to the develop
ment of assays that use the biologic
properties of target tissues to provide
specific binding agents which may have ad
vantages over the antibodies used in ana
logous radioimmunoassay systems.
A n a t o m ic a l S o urces of
G a st r o in t e st in a l H o rm o n es

Numerous cells in the gastrointestinal
mucosa have morphologic features that
suggest endocrine secretory activity. Re
cently, these cells have been examined in
detail by light microscopy and by electron
microscopy, and classified with special em
phasis on staining characteristics and on
the properties of the secretory granules.
There is now more than one classification
of these cells,84' 85 and a recent conference
attempted to accommodate the classifica
tions to a single convention, 86 which will
be followed here. An electron-microscopic
study of human specimens distinguished
four types of endocrine cells in the stomach
and three in the intestine. Only in the
gastrin-producing cells has a cell been
identified with its endocrine function.87’ 88
Gastrin or “G” cells constitute a group
that are morphologically recognizable, are
concentrated in the mid-third of the glands
of the antrum where extractable gastrin is
also concentrated, and can be shown to
contain immunoreactive gastrin-like ma
terial by immunofluorescence techniques.
Although the first observations with the
immunofluorescence technique used anti
bodies that would cross-react with pan
creozymin, the findings have since been
confirmed with a highly specific antiserum
to synthetic gastrin. 89 We have some in
formation regarding these cells in various
pathologic states : 9 0 ' 91 in patients with
duodenal ulceration they are very numer
ous and poorly granulated; in patients with
carcinoma of the stomach the G cells are
large and fully granulated. The immuno
fluorescence technique has also demon
strated apparent hyperplasia of G cells in
subjects with hypersecretion of acid in the
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range associated with duodenal ulceration.
At the present time, when we attribute
Although the immunofluorescence was not functions on the basis of cellular morpho
quantitated, it seemed to be more intense logy and distribution alone we are merely
and more widely distributed in these pa speculating. In view of the potential cross
tients. In subjects with pernicious anemia, reactivity of antibodies raised to identified
G-cell hyperplasia has been inferred from hormones, even studies with the immuno
the distribution of immunofluorescence, fluorescence technique are equivocal. How
which, however, was of low intensity. ever, we can expect soon to obtain more
These studies were done using antiserum detailed information on the morphology of
to synthetic human gastrin. Their inter the intestinal endocrine cells, and correla
pretation, in terms of the production and tion of this with functional states will be
release of hormone by the cells, is compli the next step.
cated both by the problems encountered
with immunoassays for gastrin already dis
F u r th er S tudies o f G a s t r o in t e s t in a l
cussed and by the fact that such studies
E n d o crin e F u n c t io n i n P a t h o l o g ic
give a static picture of the cells, which
S tates in M an
does not necessarily indicate their func
tional state.
Endocrine Responses in Patients
In addition to the G cells, electronWith Steatorrhea
microscopic examination has defined three
In patients with the non-tropical sprue
further types of cells in the stomach: the
syndrome, the pancreatic exocrine response
enterochromaffin cell, or “EC” cell; the “B” to exogenous pancreozymin is apparently
cell, with distinctive granules; and the
normal. Infusion of essential amino acids
“E C L ” cell, which resembles superficially
into the duodenum provides a potent
the pancreatic beta cell.
stimulus to pancreozymin-like effects on
In the human duodenal mucosa, the
pancreatic secretion and on the gall
most easily recognized cell is the EC cell,
bladder.93 Di Magno, Go and Summerwhich, in this location, has larger granules
skill94 used these responses as a guide to
than the antral EC cells. In the duo
pancreozymin secretion in patients with
denum, the most numerous endocrine cell
sprue: gallbladder responses to duodenal
is a large granulated cell, labelled the “L ”
amino-acid infusions were diminished, and
cell, and a third duodenal endocrine cell
they attributed this to defective secretion
with small granules recognized on electron
of pancreozymin. Thus, disorders of biliary
microscopy has been labelled the “S” cell.
and pancreatic function may arise as a re
The L cell, which resembles the pancreatic
sult of diseases affecting the production of
glucagon-secreting cell, may be the source
intestinal hormones.
of enteric glucagon-like material, and the
Forell95 has suggested that bile salts
other cell types may be the sources of
have a direct or indirect pancreozymin-like
secretin and of pancreozymin. In man, at
effect on the exocrine pancreas. It remains
present, there is no information regarding
to be seen whether this is an important
the appearance of the endocrine cells of
factor regulating pancreozymin secretion or
the small intestine in pathologic states. We
modifying the effects of this hormone.
have not yet been able to correlate the
classifications of endocrine cells character
Gastrointestinal Hormones in Syndromes
ized by light microscopy and various stain
Associated
With Abnormal Exocrine
ing techniques with the classifications
Secretions
and
Tumours of
based on electron-microscopic findings,
Intestinal Origin
even in identifying the cells that contain
immunoreactive gastrin-like material.92
Hormones secreted by tumours of the
Further, although substantial quantities of gastrointestinal tract have pathophysiologic
immunoreactive gastrin can be extracted importance in at least two clinical condi
from the mucosa of the upper small in tions—the Zollinger-Ellison syndrome and
testine in man, a G-like cell has not been the syndrome of watery diarrhea without
recognized in this tissue.
hyperacidity. The former, which was dis-
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cussed in relation to application of assays
for gastrin to extracts of tissues and to
peripheral blood of Zollinger-Ellison pa
tients, resolves when the adenoma is re
moved. However, in many patients, the
tumour is malignant and cannot be re
moved completely. Some of these patients
improve rapidly after gastrectomy, and
their survival may be unexpectedly pro
longed. 96 While this may occur because
the tumours are relatively benign, in
several instances the neoplastic tissue ob
jectively regressed. Indeed, it was this ob
servation that led to the hypothesis that
the growth of the tumour depends on a
humoral factor of gastric origin.97 Alterna
tively, continued secretion of excessive
quantities of acid may release trophic
agents from the small intestine; this too
would be prevented by gastrectomy. There
is evidence that small intestinal hormones
can have trophic effects on pancreatic
tissues; for example, crude extracts of in
testinal mucosa can induce hyperplastic
changes in the islets of the cat . 98 Thus,
gastric support of tumour growth in the
Zollinger-Ellison syndrome might be medi
ated by humoral secretions derived from
the small intestine or from the stomach.
A second clinical syndrome, probably de
pendent on autonomous secretion of
humoral agents from neoplastic gastro
intestinal tissues, consists of copious diar
rhea with disturbance of extracellular fluid
composition and gastric-acid hyposecretion." In this syndrome, tumours usually
arise in the pancreas and commonly meta
stasize. The combination of excessive in
testinal exocrine secretion with diminished
gastric-acid secretion suggested that the
syndrome might be caused by overproduc
tion of a secretin-like agent. In support of
this suggestion, it has been shown that
extracts of tumour tissues contain secretin
like biologic activity . 100 In some of these
patients, secretin-like activity has been de
tected in the peripheral blood by bio
assays.83 Both diarrhea and depression of
gastric-acid secretion may be relieved by
removing tumour tissue. However, as noted
earlier, bioassays for secretin-like activity
are not specific and, in man or in the dog,
secretin in large doses does not produce
diarrhea. Thus, at present, the circulating
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agent in this syndrome remains to be
identified.
These tumours may release humoral
agents that differ from those present in
normal gastrointestinal endocrine cells, and
such activity may represent atavistic or
distorted peptide synthesis by neoplastic
tissue. It is not easy to explain why the
tumours show such a marked predeliction
for the pancreas, not only when they
secrete hormones resembling insulin or
glucagon but also when their products re
semble hormones normally released by
endocrine cells in the intestine. However,
gastrin-like material has been identified by
immunofluorescence in the islet cells from
normal pancreas, and these cells may be
the source of gastrin activity in tumours.92
Likewise, the pancreatic islets may contain
cells that can produce secretin and pan
creozymin, and humoral agents with
trophic actions may favour the develop
ment of the tumours within the pancreas.
We may soon recognize more precisely de
fined clinical syndromes attributable to
effects of hormones resembling physiologic
endocrine secretions of the gut and pan
creas.
G astrointestinal H ormones and
Pancreatic E ndocrine F unction

Secretin or pancreozymin can release
insulin from the pancreas, and pancreo
zymin can also release pancreatic gluca
gon.2 2 We have increasing evidence that
regulation of the endocrine pancreas by
gastrointestinal hormones is physiologically
and pathophysiologically important. For
example, glucose absorbed from the gastro
intestinal tract is disposed of more effi
ciently than glucose delivered parenterally102' 103 and this is not due simply to
hepatic uptake of glucose from the portal
blood. 1 0 4 , 103 After glucose ingestion blood
levels of immunoreactive insulin106- 107 or
insulin-like activity108 are higher than
levels attained after intravenous glucose
infusion in man. These observations re
vived the idea that the intestine might
mediate the stimulation of insulin secretion
during absorption of nutrients. Now that
we know that secretin , 20 pancreozymin, 21
or glucagon26 can stimulate insulin release,
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and that biologic109 and immunoreactive110
glucagon-like materials can be derived
from the intestine, these agents become
candidates for roles in mediating intestinal
effects of pancreatic endocrine function.
As noted earlier, studies with the immuno
assay for secretin suggest that this hor
mone contributes to stimulation of insulin
secretion when man ingests glucose. The
role of intestinal glucagon is not clear; this
material is composed of at least two differ
ent agents and both are immunochemically
distinguishable from pancreatic gluca
gon. 111 While it seems that a component
of intestinal glucagon can stimulate insulin
secretion, the amounts released in response
to glucose ingestion probably cannot pro
duce this effect. 112 With respect to pan
creozymin, available evidence does not
suggest that the intake of physiologic
amounts of glucose leads to secretion of
this hormone, 113 but pancreozymin is cer
tainly released in response to mixed meals.
The most potent stimulus to pancreozymin
secretion appears to be protein intake.
When protein alone is ingested, this hor
mone may be an important stimulus to
insulin secretion, and its stimulation of
pancreatic glucagon release may help to
maintain blood glucose concentration in the
face of increased insulin secretion.20
The effects of extracts of intestinal tissues
on insulin release from slices of pancreas
or from isolated pancreatic islets39 suggest
that the identified hormones can cause
insulin release by direct action on the
pancreas; 114 however, these studies also
suggest that intestinal tissues may contain
other unidentified agents with similar
activity. 115 While an unidentified hormone
may contribute to the intestine’s action on
the endocrine pancreas, probably secretin
has the major effect in man. As pointed
out earlier, secretin probably takes part
in continuous interactions with other hor
mones affecting intermediary metabolism,
and the acute responses to ingestion of
food are superimposed upon these. Ab
normalities of the endocrine function of
the gut may be present in disorders of
metabolism, such as diabetes mellitus, 116
in which there are no obvious defects in
digestive function. It seems likely that we
will recognize further interactions between
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the intestinal endocrine system and other
endocrine mechanisms affecting metabolism
and homeostasis. Finally, interactions of in
testinal endocrine secretions with the nerv
ous system in regulation of other functions
will probably prove to be physiologically
important, for example, the inhibition by
atropine of the insulin response to glucose
absorbed from the gut—an effect not seen
with parenteral administration of glu
cose. 101
C o n clu sio n

The availability of pure preparations of
humoral agents derived from the gastro
intestinal tract has led us to recognize the
broad and overlapping ranges of their
actions. The effects of agents so far
identified appear to cover the range of
actions attributed to endogenous hormones.
However, within this range, there may be
many unrecognized hormones with im
portant physiologic activities. Our experi
ence with immunoassay systems developed
with the identified agents suggests that the
endogenous hormones may be present as
variants of the purified peptides derived
from extracts. Interactions with the nervous
system and among the hormones may
affect both the secretion and the effects
of these agents. The regulatory functions
of the intestinal hormones are apparently
integrated into physiologic systems, which
affect the disposal and the metabolism of
nutrients as well as their digestion and ab
sorption.
In spite of these complexities, recent
technical developments promise to further
our understanding of important patho
physiologic mechanisms in gastrointestinal
diseases affecting exocrine secretions, in
clinical syndromes associated with en
docrine tumours of gastrointestinal origin,
and in disorders of metabolism with
primary or secondary abnormalities of the
gastrointestinal endocrine system.
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R esu m e

Depuis quelques annees, des preparations pures,
composees de substances humorales, et extraites
du tube digestif, sont maintenant disponibles. On
a determine l’ordre naturel de l’acide amine lequel
est present dans les gastrines de diverses especes,
dans la secretine porcine et dans la pancreozymine-

N ovem ber 1971

UPPER ALIMENTARY BLEED IN G

eholecystokinine; puis on a etudie la pharmacologie
de ces hormones. Grace a ces etudes, on a decouvert l’etendue et le double emploi des effets
propres aux hormones reconnues du systeme
gastrointestinal. Par suite d’etudes physiologiques
et erudites, on constate que leurs effets semblent
etre analogues a ceux des hormones endogenes.
Cependant, compte tenu de leurs actions a double
emploi, il est fort possible qu’il existe des hor
mones actuellement non identifiees dont les
actions physiologiques sont d’une grande im
portance. Notre experience avec les systemes
d’essais immunologiques et congus pour les hor
mones reconnues nous montre aussi que les hor
mones endogenes peuvent etre presentes sous
forme de variantes des peptides depures et de
rives des extraits tissulaires. Les possibilites de
telle hormone ainsi que des interactions des hor
mones reconnues du systeme gastro-intestinal,
dont on soupgonne la presence depuis longtemps,
avec le systeme nerveux restent a etre reconnues.
De plus, il est a remarquer que les hormones
gastro-intestinales lesquelles reglent les secretions
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d’exocrine dans le tube digestif sont integrees a
des systemes physiologiques lesquels reglent les
secretions internes du pancreas, et possiblement de
d’autres glandes endocrines. Ces hormones affectent done l’elimination et le metabolisme des sub
stances nutritives ainsi que leur digestion et leur
absorption. Par consequent, il apparait que des ano
malies metaboliques peuvent etre repetees dans des
aberrations de la secretion emise par les hormones
gastro-intestinales. Cependant, de telles deviations
ne peuvent etre interpretees uniquement en rap
port avec des anomalies des fonctions digestives
de l’intestin.
Malgre ces complexicites, de nouvelles deeouvertes scientifiques nous aideront a approfondir nos connaissances ayant trait aux mecanismes pathophysiologiques de grande imoortance dont on retrouve dans les syndromes cliniques et associes aux tumeurs des glandes endo
crines, d’origine gastro-intestinale, et dans des
troubles metaboliques demontrant des anomalies,
d’importance primaire ou secondaire, dans le
systeme endocrinien du tube digestif.

MANAGEMENT OF ACUTE U PPER ALIMENTARY B L E E D IN G 0
W. C. WATSON, M.D., Ph.D., F .R .C .P .(G la s.),t London, Ont.

W hen a patient presents with acute upper
alimentary bleeding, the questions to be
answered are:
(1 )
(2 )
(3 )
(4 )
(5 )
(6 )
(7 )

Is he still bleeding?
Why is he bleeding?
Where is he bleeding?
How much has he bled?
Is he likely to bleed again?
What needs to be done now?
What may need to be done in the
near future?

Questions 1 to 5 concern the diagnosis and
current assessment of the patient. Ques
tions 6 and 7 relate to treatment.

D iagnosis
Diagnosis is the best prelude to treat
ment and this applies as much to acute
“From the Gastrointestinal Unit, Department of
Medicine, Victoria Hospital, University of Western
Ontario, London, Ont.
tAssociate Professor of Medicine and Director of
Gastroenterology, Victoria Hospital.

alimentary bleeding as to any other condi
tion. Occasionally, management may have
to proceed in the absence of a firm diag
nosis, but early diagnosis and specific
treatment of a precise source of hemor
rhage are life-saving1 and many unneces
sary operations are avoided by an early
precise diagnosis.2
The key steps in the diagnosis are the
history, clinical examination, observations
of gastric aspiration, endoscopy, radiology
and, in a proportion of cases, exploratory
laparotomy with or without gastrotomy.
The history may be obtained from the
patient or relatives. It is diagnostically and
prognostically
important
to
establish
whether bleeding has been solely as hematemesis, as melena, or the two combined.
In a recent large series of over 2000 pa
tients,3 mortality was related to the type of
bleeding as follows: hematemesis only—
12%, hematemesis and melena—9.4% ,
melena only—5.4% . These figures reflect
the fact that hematemesis alone is more
often associated with rebleeding4 and that
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hematemesis as such is more directly asso
ciated with bleeding from esophageal
varices and gastric ulcer, the two condi
tions that bear the highest mortality.
The nature of a hematemesis is helpful.
Bright red blood welling effortlessly out
of the mouth usually indicates bleeding
from esophageal varices, whereas the
vomiting of small amounts of “coffee
grounds” or altered blood suggests duo
denal bleeding, or less severe gastric bleed
ing. If patients are alert enough to estimate
the volume of blood lost by hematemesis,
about one-half will be accurate to within
0.2 l.5 On the other hand, if the patients
have been drinking alcohol they are likely
to overestimate the volume lost, often by
large amounts.
A history of dyspepsia associated with
a known organic lesion may give a direct
clue to the diagnosis, but, according to
Palmer,0 this may be misleading in as many
as 40% of patients, in whom the bleeding
will be due to another lesion. A similar
degree of error was also reported by Mailer
e t al.7 A common example of this kind of
confusion is the patient with a known duo
denal or gastric ulcer who takes an aspirincontaining analgesic for the relief of pain
and bleeds from salicylate-induced ero
sions. McCray et al.8 described a series
of 27 patients with known varices who
presented with acute bleeding. Only five
(18.5% ) were found to be bleeding from
the varices. The causes in the remainder
were gastric erosions (16), duodenal ulcer
(tw o), gastric ulcer (tw o), unknown
( two).
A history of recent or current drug in
gestion is essential. The main drugs to be
asked about are aspirin, alcohol, anti
coagulants, phenylbutazone and steroids.
Since the report by Muir and Cossar,9
many papers have testified to the role of
aspirin in the causation of alimentary
bleeding. However, the incidence of the
association varies in the different series and
with the diligence and pertinacity with
which the history is taken. Specific trade
brands should be asked about by name.
Common
examples
are
Alka-Seltzer,
Bromo-Seltzer, Anacin, Instantine, Frosst
tablets, and Darvon ( compound tablets). It
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is not generally known that the “seltzers”,
drugs widely advertised for upset stomach
(which must include a great deal of ulcer
dyspepsia or alcoholic gastritis), contain
aspirin. Also, many patients who have
peptic ulcer are not specifically advised by
their doctors to avoid aspirin-containing
drugs. This is a failure of preventive medi
cine. Many elderly people take aspirin on
retiring as a kind of hypnotic or sedative,
and this timing of aspirin ingestion seems
particularly prone to induce bleeding. The
damaging effect of aspirin on gastric
mucosa is well established, even in normal
individuals.10’ 11
A history of a bleeding tendency, easy
bruising, nose bleeds or a family history
of bleeding, may reveal a predisposing
cause for alimentary bleeding. Curiously,
hemophilia is rarely encountered in the
patient with acute intestinal bleeding.
The clinical examination contributes to
the diagnosis and hemodynamic assess
ment of the patient. Spider nevi, palmar
erythema, hepatosplenomegaly and ascites
indicate cirrhosis, portal hypertension and
bleeding varices. A caput medusae and
hemorrhoids reinforce this suspicion. Jaun
dice may be due to cirrhosis but, if due
to other causes, it may indicate hypoprothrombinemia secondary to poor ab
sorption of vitamin K. Angiomas and tel
angiectatic lesions of the nose, lips and
mouth suggest Rendu-Osler-Weber disease,
and larger blue rubber-bleb nevi suggest
Bean’s syndrome. Pigmentation of the lips
and mucocutaneous junction may reveal
the Peutz-Jeghers syndrome, and paperthin scars or inelastic skin, the EhlersDanlos syndrome. These disorders are
interesting, but rare, and constitute a small
proportion of the large series of gastro
intestinal bleeds.
Pulse rate and blood pressure contribute
to the assessment of the hemodynamic
status of the patient. Pulse rate may bear
a poor relationship to the amount of blood
lost5 because it is affected by excitement,
alcohol, anxiety and other medications. On
the other hand, blood pressure on admis
sion is a valuable sign which correlates
well with blood loss and prognosis. Schiller,
Truelove and Williams3 found that when
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the admission blood pressure was equal
to or above 100 mm. Hg, the mortality rate
was 8% , when it was between 80 and 99
mm. Hg, it was 17%, and when it was
below 80 mm. Hg, the rate was 33%.
Laboratory Investigations
The essential data are the hemoglobin
level, hematocrit, leukocyte count, platelet
count, prothrombin index and partial
thromboplastin time. The blood urea nitro
gen is a clue to underlying renal disease,
and the serum proteins, bilirubin, alkaline
phosphatase and transaminase levels con
tribute to the assessment of liver disease.

tained. Then, if the Ewald tube has been
used, it should be replaced by a Levin
tube. Thereafter, intermittent or continu
ous suction is used to monitor for bleeding.
Occasionally, even with a wide-bore tube,
blood clot will block the tube and prevent
adequate aspiration. There is a general
belief, unproven, that cold-water lavage
contributes to hemostasis. There is no
opinion that it does harm.
Special Investigations
Since 1952 Palmer6,12 has been the chief
advocate of the “vigorous diagnostic ap
proach” to alimentary bleeding. He and

TABLE I. — I n cid en c e

of C a u s e s of U p p e k G a s t r o in t e s t in a l B l e e d in g C o m p a r in g C o n s e r v a t iv e
I n v e st ig a t io n 3, 16,17 W it h t h e V ig o r o u s D ia g n o st ic A p pr o a c h .6, 13,16
F ig u r e s a r e P e r c e n t a g e s

Reference no.
Diagnosis:
Duodenal ulcer............... ........
Gastric ulcer................... ........
Gastritis/erosions.......... .......
Hiatus hernia...........................
Varices........................................
Gastric carcinoma.......... ........
Miscellaneous................... ........
No diagnosis..................... ........

3

16

17

6

13

16

29.0
15.1

36
14
4
4
2
3
3
34

35.0
16.5

27.7
12.6
20.2

19.3
10.0
2 0 .0
2 .0
18.7
2 .0
6 .2
18.7

18
18
32
4
2
4
8
14

...
...

2 .4
2 .2
25.2
26.2

Electrocardiogram
Electrocardiography should be performed in all patients admitted following
acute upper alimentary bleeding, especially
in those over 50 years of age. Myocardial
infarction is a well-established complica
tion especially when blood loss is severe.
Gastric aspiration is a simple, valuable,
but often-neglected step in the manage
ment of the bleeding patient. A practical
problem is whether to use a wide-bore
Ewald tube or a Levin tube at the first
intubation. A helpful rule is to use the
Levin tube when melena is the main symp
tom or when hematemesis has been mild
or as “coffee grounds”. On the other hand,
when hematemesis has been severe and has
occurred within a few hours, the larger
tube should be used. Whichever tube is
used, the first objective is to wash out the
stomach with cold, even ice-cold, tap
water. Amounts of one to two gallons are
appropriate. Aspiration should be by hand
suction or by siphon, and should continue
until a clear or blood-tinged return is ob-

—

2 .4
2 .7
2 .7
15.1
2 5 .6

—

18.7
—

13.7
7 .0

others1,7* 13-15 have shown that the early
use of endoscopy and radiology increases
the accuracy of diagnosis and confidence
in the management of the patient. It has
also increased our awareness of the wide
range of lesions that can cause bleeding.
Lesions such as gastritis and the MalloryWeiss syndrome, which are radiologically
negative, figure more prominently in series
including early endoscopy in the diagnostic
work-up. Table I compares the incidence
of diagnoses in three series from the era of
conservative investigation, with three series
from the era of the vigorous diagnostic ap
proach. The former have a very small to
no incidence of erosions or gastritis and a
high incidence of “no diagnosis”, whereas
the latter have a high incidence of gastritis
and erosions and a smaller incidence of
“no diagnosis”.
It is a matter of opinion whether en dos
copy or radiology should be performed
first. Often the order is dictated by factors
other than preference. One reason for per
forming endoscopy first is that barium can
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spoil the view for up to 12 hours. Another
is that, although the radiologist may
demonstrate a lesion, there is no certainty
that this is the bleeding lesion. Although
the endoscopist’s view is confined to the
esophagus and stomach (the duodenoscope
has extended this) it may be obvious that
bleeding is duodenal or jejunal if fresh
blood is seen regurgitating through the
pylorus or a stoma. If a duodenal ulcer
is then shown radiologically, it is almost
certain that it is the site of bleeding. Simi
lar observations apply to esophageal
varices.
Endoscopy
Flexible fiberoptic endoscopes are suffi
ciently well established to require no ex
planation or justification. In terms of safety
and viewing capacity they are now the only
acceptable instruments for upper alimen
tary endoscopy. The well-known American
and Japanese models have individual modi
fications, but most are satisfactory except
perhaps in relation to the ease and ac
curacy with which biopsies may be taken.
The examination may be carried out in
the patient’s own bed or in a special room.
Palmer uses no sedation or premedication.
We adhere to the same routine as for elec
tive endoscopy, namely, 1.2 mg. atropine
is injected intramuscularly 30 to 60 minutes
beforehand and diazepam 10 mg. (Valium)
intravenously before the instrumentation;
the throat is sprayed with Lignocaine
(lidocaine). The atropine may be omitted
in the interests of urgency. The examina
tion may be carried out with a Levin tube
in position.
The following information is sought.
Whether there is fresh or altered blood
in the stomach; fresh blood is evidence of
active bleeding. Whether there is a definite
lesion—erosion, ulcer, neoplasm, angioma.
Whether such a lesion is the source of the
bleeding or not. Whether bleeding is oc
curring outside the stomach—duodenum,
jejunum, or esophagus. Tlius, the endo
scopic diagnosis may be direct or infer
ential. It may be complete or incomplete
and require radiologic simplification.
Those who have written about endos
copy stress that in their hands it has not
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caused rebleeding.6- 7- 13 This is our own
view. There is even the possibility that the
total management procedure associated
with endoscopy diminishes the incidence
of bleeding. The total incidence of rebleed
ing in Mailer’s series7 was 15%, whereas
in a non-endoscopic study18 it was 32%.
R adiology
This should be carried out in the radi
ology department. It is seldom that a pa
tient cannot be brought to a sufficiently
stable hemodynamic state to permit radi
ology. Barium sulfate is the preferred radio
paque medium. The value and safety of
early radiology are well established.19-21
Recently, selective angiography of the
celiac axis or superior mesenteric artery
has been employed when the site of bleed
ing remains obscure. It may either demon
strate a site of active bleeding, or it may
reveal a lesion, such as a hemangioma or
tumour, which it is reasonable to regard
as a likely source of previous bleeding.
Baum et al.,22 who pioneered the tech
nique, demonstrated experimentally that
active bleeding could be visualized only if
the rate of bleeding was greater than 0.5
ml./min. With subsequent experience of
the method,23 Baum demonstrated the
bleeding lesion in 18 of 21 patients. Reuter
and Bookstein24 had success in 11 of 16
acute “bleeders” and in nine of 13 with
chronic recurrent bleeding. In an enlarged
series25 they demonstrated a lesion in 25
of 45 acute “bleeders”. These authors
recommend that when a patient with a
history of recurrent undiagnosed upper
gastrointestinal bleeding is admitted with
an acute “bleed”, angiography should be
the first investigation. In 31 patients so in
vestigated there was a high incidence of
unusual and arcane lesions such as arterio
venous malformations, hemangiomas and
aneurysms.
M easurement of Blood Loss
When a patient is seen soon after an
acute “bleed”, the amount of blood loss
correlates poorly with pulse rate and hemo
globin level5- 7 but correlates well with
central venous pressure (CVP) and blood
pressure.26'28 Direct measurement of blood
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volume using 12BI-labelled albumin and an
automatic blood-volume computer facili
tates the recognition of those who, while
they give a history of serious bleeding,
have normal hemoglobin levels and have
not bled significantly. This can avoid un
necessary admission. Many of such pa
tients have been drinking heavily and have
confused the colour of spirit or cheap wine
with blood.5 More positively, accurate
assessment of blood loss increases, the ac
curacy of transfusion orders.
Measurement of central venous pressure
(right atrial pressure) is more generally
practicable, and if the manometer is ac
curately set up and maintained, it pro
vides a valuable monitor of the bleeding
state of the patient and of his transfusion
requirements.
Andersen27 used the CVP as a primary
indication for operation, even in the ab
sence of a diagnosis. A patient qualified
for operation on the grounds of major
arterial hemorrhage if (1) there was a drop
in CVP of at least 2 mm. PPO/min., (2)
there was a bleeding rate of 600 ml./hr.
based on the transfusion rate needed to
maintain a normal CVP, (3) there was
intermittent hemorrhage. His contention is
that patients with the above criteria have
bleeding arteries which need surgical
management and are so gross as to be
found easily. Radiologic and endoscopic ex
aminations were not performed as a rule.
Northfield and Smith28 support Andersen
in general terms. They found the CVP use
ful in assessing transfusion requirements
and detecting the high-risk patient. Their
normal value was a reading of 5 cm. HaO
with zero 4 cm. below the manubriosternal
junction in the supine position. They
recommend that patients be transfused to
a normal blood volume, which is indicated
by a normal CVP. In their opinion re
bleeding is likely if the initial transfusion
requirement is six units or more. They
state that rebleeding can be positively
diagnosed if the CVP falls from 4 cm.
IPO or above to zero in five hours.
The measurement of CVP must be per
formed accurately. In a brief critique of
the method, Eliahou et al.29 confirm its
value in the management of uncomplicated
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hemorrhage, but advise caution in the
management of shock in such non-hemorrhagic conditions as chest injury, blast
lung, cardiac decompensation, or when
the patient is on a respirator.
Fecal blood loss is easily measured using
51Cr-labelled red cells,30 but is of no value
in the monitoring of alimentary bleeding
because of the valuation in the passage of
feces.31
T reatm ent

The management of acute gastroin
testinal bleeding is best undertaken by a
team consisting of “a keen physician and a
somewhat reluctant surgeon”.32 The ma
jority of patients are managed without
surgery—75% to 80% in most series.
Blood transfusion is the mainstay of
treatment and is required in about 75% of
patients.3 Schiller, Truelove and Williams
found that more than one-half of those
transfused required more than five bottles
of blood. Some authors advocate trans
fusion to maintain a normal CVP and hence
a normovolemic state.27,28 This concept
has been challenged.16 It has been shown,
during experimental arterial bleeding in
dogs,33 that animals that are transfused
have the largest blood loss and the longest
bleeding times. Blood loss and bleeding
times diminish when the dogs are un
treated, rendered hypovolemic before
bleeding is induced, given a vasodilator
drug, or given a vasodilator drug and
transfused, in that order of progression.
Mean blood loss in the untreated dogs was
323.7 ml. compared with 1522.4 ml. in the
transfused dogs and fell to 25.8 ml. in
animals given a vasodilator.
For various reasons, not least medico
legal, it is difficult to refrain from trans
fusing the bleeding patient, but the policy
of transfusing to maintain a normal CVP
or blood pressure can be legitimately ques
tioned. It is our practice to transfuse to
maintain the hemoglobin level between
10 and 11 g./lOO ml.—a program that is
especially important in the elderly patient
to avoid confusion arising from cerebral
ischemia. In Schiller’s series, the lowest
mortality occurred in those not transfused
or given less than five units of blood. While
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this relationship is probably due to the less
severe bleeding in these patients, it is pos
sible that, in some of them, the favourable
factor was the small amount of the trans
fusion.
When transfusion requirements are large,
say over 15 units, the bleeding may be
aggravated by citrate toxicity. This can
be treated by intravenous calcium.
Drugs should be used sparingly and
rationally. Unless the patient is in pain he
does not need an analgesic. Pressor agents
are contraindicated. If the patient has been
on anticoagulants they should be stopped
at once. The antidote for Coumadin drugs
is vitamin Kj and for heparin, protamine
sulfate. If liver function is good, low pro
thrombin levels will be corrected in a few
hours by the parenteral administration of
vitamin K.
Patients with gastrointestinal bleeding
are often significantly deficient in vitamin
C,34 yet this fact is seldom regarded in
management. It is our practice to give
every patient admitted with an acute ali
mentary “bleed”, 500 mg. of ascorbic acid
intravenously at once, and to repeat this
dose orally or parenterally daily thereafter
until the bleeding state is controlled. The
substance is cheap and safe and the reasons
for giving it rational, though its thera
peutic value has not yet been proved by
a clinical trial.
Sedation should be administered to the
anxious or agitated patient, but with care
in the elderly and not as a substitute for
the treatment of hypovolemic shock. Seda
tive drugs must be used sparingly in pa
tients with liver disease and the orders for
these should be reviewed daily.
Gastric cooling, first introduced by Wan
gensteen et al. in 1958,35 is no better than
conservative management.36
Selective arterial drug infusions have
been advocated for the control of massive
bleeding. In a preliminary report, Rosch
et a l 37 claim to have controlled bleeding
successfully in 10 of 11 patients using
selective infusion of the superior mesen
teric artery with propanolol and epineph
rine. A major difficulty seems to be the
evanescence of the drug action, and a
larger study seems to be warranted before
this technique can be recommended.
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The dietary m anagem ent of peptic ulcer
and its complications remains an area of
black magic in modern medicine. As soon
as vomiting ceases, if there is no immedi
ate prospect of surgery and if the patient
feels like it he should be allowed to eat
food of his own choice. There is no evi
dence that food causes bleeding. In so far
as many patients with peptic ulcer have
been eating a diet of inferior nutritional
value (often on medical advice) the
quicker they return to a proper diet the
better.
Surgical I ntervention

The indications for surgical intervention
are as follows:
(1 ) Unmanageable bleeding or massive
hemorrhage defined as “acute blood loss
sufficient to reduce the circulating red cell
mass to below 18 ml./kg. body weight or
60% of estimated normal”,38 or major
arterial hemorrhage as already defined on
the basis of the CVP measurement.27 Katz
et al.13 defined “severe bleeding” as a
hemoglobin level of 8.5 g./lOO ml. or less
at the time of admission, or the trans
fusion of four units of whole blood during
the first 24 hours. Using these criteria, the
leading causes of severe bleeding requir
ing operation were varices, duodenal ulcer
and acute gastric ulcer, in that order.
(2 ) Rebleeding is an indication for
operation, especially in the elderly. It may
be detected by fresh melena or hematemesis, by rising pulse rate, falling hemo
globin and blood pressure, or by a fall
ing CVP. Patients admitted with hematemesis have a higher incidence of re
bleeding than those with melena,4 and pa
tients who have not bled for 48 hours are
unlikely to bleed again in the near future.
(3 ) If transfusion requirements reach 10
units.
(4) When the patient has a rare blood
group and there is uncertainty about the
prognosis.
(5) In relation to the diagnosis; other
conditions being equal, operation for bleed
ing duodenal or gastric ulcer is indicated
before procedures for gastric erosions or a
Mallory-Weiss tear.
(6 ) Age is a consideration. Patients over
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the age of 50 are at greater risk from re
bleeding,3 although the incidence of re
bleeding is no higher in the older age
group, nor is it higher in men compared
to women.4
(7) The special problems that relate to
esophageal varices.
The surgeon assumes his task either
knowing the precise diagnosis or not. His
objectives are to identify the bleeding site,
stop the bleeding and try to prevent its
recurrence. When the source of bleeding
has been identified, it should be stopped at
once either by oversewing or by applying
a clamp. This is only feasible in certain
circumstances, such as bleeding from a
single ulcer, and is not feasible if the
bleeding is caused by multiple erosions.
Freeark, Norcross and Baker39 described
their experience in emergency operations
for acute gastrointestinal bleeding in 77 of
212 patients in whom preoperative investi
gation had not established the diagnosis.
At operation a meticulous exploration of
the upper abdomen was carried out in an
attempt to establish the cause of bleeding.
But either because nothing was found, or
because the findings were inconclusive,
gastrotomy through a 15-cm. anterior in
cision was carried out. A bleeding site was
accurately identified in 74 of the patients.
Unsuspected gastric and duodenal ulcers,
varices, Mallory-Weiss tears, gastritis, pan
creatic cysts and gastric neoplasms were
among the lesions encountered. A signifi
cant number of the bleeding sources could
not have been controlled by empiric resec
tion of the distal two-thirds of the stomach.
However, they caution that complications
directly related to the long gastrotomy are
frequent unless adequate precautions are
taken to prevent their occurrence.
Until 1958, partial gastrectomy was the
operation most frequently employed, par
ticularly for bleeding peptic ulcer, and
depending on many factors, mortality
figures varied from 5% 40 to 15%.18 Then
Smith and Farris41 suggested the use of
more conservative surgery, namely direct
suture of the bleeding site with vagotomy
and a drainage procedure. Carruthers et
al.i2 reported their experience in 117 pa
tients, 55 of whom had either a Polya or
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Billroth I gastrectomy and 57 of whom had
a vagotomy and pyloroplasty with suture
of the bleeding vessel. Their conclusions
were in general agreement with those of
Foster, Hunt and Dunphy.43 Mortality in
the conservative group was 7% compared
with 18% in the radical group. They
stressed that their good results were mainly
in patients with bleeding duodenal ulcer.
They thought that comparable results
might be obtained with gastric ulcer, but
were less hopeful regarding erosions. Their
experience differed from that of Kelley,
Grant and Elliott44 who found no differ
ence in mortality rate when comparing the
radical and conservative methods, and of
Akin and Sullivan45 who had poor results
in a small series of 20 patients. Opinions
were mixed regarding the incidence of re
bleeding after either type of operation.
The recent operative data of Schiller,
Truelove and Williams3 are persuasive. In
their series of 2149 patients studied over
a 15-year period, the highest mortality rate
was associated with the Polya procedure
(21.1% ), the Billroth I operation occupied
a middle position (13.2% ), and the best
result was with vagotomy and drainage
(8.0% ). The trend applied to both sexes.
The poor mortality rate for the Polya
operation applied throughout the 15 years
of the review. Analysis of their data showed
that the improved results applied almost
entirely to the over-60 age group. V ag
otomy and drainage was the most success
ful operation for duodenal and gastric
ulcer and, for the other conditions, it was
as good as a Billroth operation and better
than the Polya. Regarding rebleeding, the
differences between the three operations
were marginal.
In spite of the better surgical results
associated with the shift to the vagotomy
and drainage operation, Schiller, Truelove
and Williams found no overall improve
ment in the mortality of patients admitted
with acute upper alimentary bleeding.
They concluded that this was because
fewer patients were being submitted for
emergency operation. They advocate that
emergency procedures be performed more
frequently and that vagotomy and drain
age be the operation of choice for all
causes of bleeding, except varices.
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E lective Surgery

Once bleeding is controlled, operation
may be required to prevent further bleed
ing, for the definitive treatment of the
primary lesion (or both). If operation is
indicated for either of these reasons, it
should be performed as soon as possible,
taking into consideration all relevant facts.
Elective surgery will be more specifically
related to the diagnosis. In our opinion, a
patient who has bled from esophageal
varices should have an appropriate pro
cedure as soon as he is fit enough. If there
is delay beyond this point there is a high
risk of rebleeding with a sharp rise in mor
tality rate. In bleeding duodenal ulcer there
are differences of opinion as to the value
of operation in preventing relapse. Some
authors consider the relapse rate after
operation to be high, although their re
sults are better than from medical treat
ment alone.46"48 A recent paper,49 however,
reports substantially better results after
surgery. The differences could be due to
variations in the natural history of the dis
ease and in operative practice in different
countries.
Summing U p

There are no short cuts and there are no
absolute rules. There are valuable guide
lines.
Whether the patient is first seen by the
physician or the surgeon they should col
laborate as soon as possible. This does not
always require the physical presence of
the partner. With time, trust in the other’s
judgment develops.
No matter how ill the patient, a history
should be obtained and a quick but
thorough clinical examination carried out.
With the exception of bleeding esophageal
varices, exsanguination is seldom an im
mediate threat. If pulse, blood pressure and
hemoglobin are satisfactory (e.g. less than
100/min., more than 100 mm. Hg systolic,
and more than 10 g./lOO ml.), the patient
is in no immediate danger and detailed in
vestigation can proceed at once. Endoscopy
followed by radiology is the better order,
but is not obligatory. Either is better than
none.
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If the patient’s condition is poor, trans
fusion should be initiated and regulated
according to blood pressure, CVP and
hemoglobin. It may not be desirable to try
to restore these to normal. Once trans
fusion is under way, other investigations
can continue.
Coagulation disorders should be sought
and appropriate therapy given or stopped.
There is a case for the administration of
vitamin C to all patients with acute ali
mentary bleeding.
If emergency operation is required it
should usually be undertaken during the
first 48 hours after admission. With the ex
ception of bleeding varices and the possible
need for diagnostic gastrotomy, suture and
vagotomy with a drainage procedure would
seem to be the operation of choice at the
present time.
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R esu m e
La clef du succes dans l’hemorragie aigue de
l’appareil digestif superieur est le diagnostic precoce quant au siege et a la nature de la lesion.
Les principales etapes du diagnostic sont l’histoire
clinique, l’examen clinique, Inspiration du contenu
gastrique, l’endoscopie et la radiologie. II est
important de questionner le malade au sujet de
certains medicaments pris recemment, notamment
aspirine, anticoagulants et alcool. Le pouls pris a
l’arrivee renseigne mal, mais la tension arterielle
donne une bonne idee de la perte de sang et
permet de preciser un bon pronostic. L ’endoscopie
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effectuee avec des instruments en fibre optique
est une methode sans danger qui, conjointement
avec diverses techniques radiologiques, permet
d’obtenir un diagnostic precoce, precis dans au
moins 90% des cas. On peut evaluer la perte de
sang par mesure directe du volume sanguin on la
surveiller par enregistrement continu de la pression veineuse centrale. La transfusion sanguine
est J a clef de voute du traitement, mais comporte
un danger, celui de Texces de transfusion. Le
traitement chirurgical s’impose chez environ 20%
des malades. La vagotomie et le drainage sont
greves de la mortality la plus basse.

COMPARATIVE E FFE C T S OF WHOLE BLO O D , HEMODILUTED, AND
CLEAR PRIMING SOLUTIONS ON MYOCARDIAL AND BODY
METABOLISM IN MAN*
EMERSON A. MOFFETT, M.D.,t ROGER D . W HITE, M.D.,t
GEORGE D. MOLNAR, M .D 4 and DW IGHT C . McGOON, M.D.,§

Rochester, Minn., U.S.A.
S in c e 1959,1 when various types of clear
or non-blood solutions began to be used
for priming the bubble oxygenator, intro
duced in 1955,2 this system has been used
more for whole-body perfusion than any
other. Thousands of perfusions have been
successfully accomplished with it through
out the world.
Using a clear prime in the popular
Travenol disposable bubble oxygenator we
studied myocardial and body metabolism
during and after perfusion in six patients.
The results were compared with those ob
tained in two groups of five patients each.
In one group, the patient was perfused
with diluted acid-citrate-dextrose (ACD)
blood,3 and in the other, perfusion was
with fresh heparinized whole blood,4 using
the vertical-sheet oxygenator at 30° C. in
"Supported in part by Research Grant GM-14919
from the National Institutes of Health, Public
Health Service.
■{"Department of Anesthesiology, Mayo Clinic and
Mayo Foundation, Rochester, Minn.
$Department of Internal Medicine, Mayo Clinic
and Mayo Foundation.
§Department of Surgery, Mayo Clinic and Mayo
Foundation.

both groups. In addition to cardiac output
we determined arterial and coronary sinus
blood concentrations of oxygen, acid-base
parameters, electrolytes, and energy pro
ducing substrates throughout operation
and for the next three days.
P a t ie n t s Stu d ied

Six patients underwent open-heart sur
gery; perfusion with the bubble oxygenator
was carried out at 30° C. Information on
the six patients is shown in Table I. The
group included one child (aged 6 years)
and five adults whose ages ranged from 17
to 48 years. Body weights varied from 46.5
to 175 lbs. The shortest perfusion time was
47 minutes, and the longest was 137 (mean
83 minutes). The three youngest patients
underwent repair of congenital defects, the
other three had valvular replacements.
Patient 3 continued to have heavy drain
age from the chest tubes, and was re
explored five hours after operation. No
other major complications occurred, and
all patients left the hospital in an average
of 13.6 days. Mean perfusion time was 82
minutes in the hemodiluted group and 87
minutes in the whole-blood group.

November 1971

PRIMING SOLUTIONS IN M AN

383

T A B L E I .— C l i n i c a l D a t a o n S i x P a t i e n t s U n d e r g o in g O p e n - H e a r t S u r g e r y

Weight
{lbs.)

Surface
area
{sq. m.)

46.5

NYHA
class

Perfusion
time
{min.)

0.83

I

65

1.88

III

47

98

1.47

III

137

175
129.5
167

2.00
1.68
1.87

II
III
II

90
82
79

Patient
no.

Sex

i

F

6

2

M

17

144

3

F

18

4
5
0

M
F
M

44
48
48

M ethods

of

Age
{years)

Study

Techniques o f anesthesia for all groups
were as previously outlined:3 nitrous
oxide-oxygen with small amounts of halothane and succinylcholine. Only patient 5
had an endotracheal tube left in at the end
of anesthesia, for assisted ventilation over
night, The fractional concentration of oxy
gen in inspired air ( F i 0 2 ) , before and
after perfusion, was 0.4; at the end of
operation, 1.0; and after the operation
(given by loose facepiece), 0.3 to 0.5.
An arterial blood sample was taken be
fore anesthesia with the patient breathing
air. Subsequent samples were obtained
through a transfemoral catheter in the
aorta or from the pump oxygenator. After
thoracotomy, the surgeon inserted a small
catheter deep into the coronary sinus.
Simultaneous samples were drawn subse
quently from these sites. The coronary
sinus catheter and the catheter placed in
the left atrium were brought out through
the chest wall for postoperative sampling
and dye injection. The schedule of blood
sampling is shown in the figures.
For the adults in the clear-prime group,
the priming solution consisted of 1500 ml.
of 5% dextrose in 0.2% NaCl, 100 ml. of
0.3M tromethamine (T H A M ), and 2000
units of heparin. For the child, the amount
of dextrose was reduced to 1000 ml. and
the amount of THAM was reduced to 65
ml. In the hemodiluted group, the prime
was 60% ACD blood diluted with 5%
dextrose in 0.45% NaCl, plus 65 ml. of
THAM3 per 500 ml. of blood. In the third
group, the pump oxygenator was primed
with fresh heparinized whole blood.4 Oxy
gen and carbon dioxide (10 I./min. and
0.2 l./min. respectively) flowed through
the oxygenator. Mean arterial flow for the

Operation
Closure, ostium primum,
atrial septal defect
Closure, atrial septal defect in
corrected transposition
Correction, complete
atrioventricular canal
Aortic valve replacement
Mitral valve replacement
Aortic valve replacement

clear-prime group averaged 2.26 l./m in ./
sq. m. Maintenance of a steady flow o f that
magnitude required the addition of further
volume to the circuit. Patients 3 and 5 each
had 2500 ml. of ACD blood added, whereas
patients 2 and 6 needed 1000 ml. each.
Volumes o f blood added to patients 1 and
4 were 250 ml. and 1500 ml., respectively.
Also given with each 500 ml. of blood
added to the oxygenator were 150 ml. of
5% dextrose in 0.2% NaCl, 65 ml. of 0.3M
THAM, 0.5 g. of CaCl2 and 2 mEq. o f KC1.
Arterial flows in the other two groups were
similar to those of the clear-prime group.
Cardiac output was measured by dye
dilution, after the injection of indocyanine
green into the left atrium, with sampling
through the aortic catheter.
All biochemical determinations on blood
were done as previously reported3 except
that lactate and pyruvate levels were de
termined by enzymatic,6 rather than nonenzymatic, methods. Samples were iced,
and p 0 2, pCOo and pH were measured by
electrodes at 37° C. within 10 minutes.
Corrections were made when the patient’s
temperature was below 36°C. Plasma con
centrations o f sodium, potassium and cal
cium were measured, and plasma osmo
lality was determined. Energy producing
substrates measured across the myocardium
were glucose, non-esterified fatty acids
(N E F A ), total ketone bodies, lactate, and
pyruvate. Arterial concentrations of plas
ma immunoreactive insulin7 and human
growth hormone8 were measured by
double-antibody radioimmunoassay.
Analyses o f paired data in the clearprime group by the Student t test were
done, comparing arterial and coronary
sinus levels o f parameters at each sample
time. Analyses of unpaired data were
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R esu l t s

Mean concentrations of all variables in arterial and coronary
sinus blood of the clear-prime group are presented, with mean

d
L

-v
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arterial levels of the hemodiluted and whole-blood groups ( Figs.
1-8). Because insulin and growth-hormone concentrations were
not determined in the hemodilution group, mean values of these
hormones from a seriously ill group (Group 2 from another
study)9 were used in Figs. 5 and 6. Perfusions and manage
ment of these patients were identical in all respects with those
in the hemodilution group.

made, comparing arterial concentrations of each parameter in
the clear-prime group with arterial levels in the other two
groups.
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Fig. 1.—Oxygen tension and content. In both the clear-prime and
hemodilution groups, oxygen content was lower during perfusion than in
the whole-blood group. The oxygen content decreased on days 3 and 4
in all three groups.

am p.m. a n p.m. am p.m.
' Pre
}—Perfusion—j
induction
- 2—
-3—
---------------- Day 1—
Fig. 2.—Acid-base balance. Respiratory alkalosis was
present during operation in all three groups. Buffer base in
creased after operation, with significantly higher concentrations
by day 3 in the clear-prime group compared with the hemo
dilution group.
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120

Pre
induction

— 4—
■Day 1—2—
-3 —
Fig. 5.—Insulin and glucose. Insulin level was significantly higher
in the clear-prime and seriously ill9 groups at the end of perfusion and
after perfusion than in the whole-blood group. Glucose level was higher
in the clear-prime group during perfusion than in the hemodilution and
whole-blood groups.
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Fig. 6.—Growth hormone and non-esterified fatty acids. Growthhormone level was significantly higher in the clear-prime group than in
the seriously ill group9 at mid-perfusion; in both groups, it peaked after
perfusion. NEFA level followed a similarly elevated pattern in all three
groups.
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TABLE II.— S i g n i f i c a n t

D if f e r e n c e s in
g o in g

A r t e r ia l C o n c e n t r a t io n s B e t w e e n T w o G r o u p s U n d e
O p e n -H e a r t Su rg ery

Clear-prime group greater
than hemodiluted group

Clear-prime group less
than hemodiluted group

Buffer base
pH
Hemoglobin
Hematocrit
pCOa
Potassium
Sodium
Calcium

Day 3 (p.m.) and dav 4
Preinduction
None
None
None
Preinduction
None
Day 4 (a.m.)

Osmolality
Glucose

None
Early perfusion through
remainder of day 1 and
day 3 (a.m.)
30 min. after perfusion
and end of operation
Day 2 and day 3 (a.m.)

None
None
Day 3 and day 4 (a.m.)
Day 3 and day 4 (a.m.)
End of operation
None
End of operation
Early perfusion through
day 2 (a.m.)
Day 2 (a.m.)
None

Variable

Non-este rifled
fatty acids
Total ketone
bodies

Cardiac index in patients 3 to 6 (Table
I) averaged 2.2 and 2.8 l./m in./sq. m. be
fore and after perfusion. Two hours after
operation, the index was lowest at 2.1. At
3:00 p.m. on days 2 to 4, the mean index
was 2.2, 2.6, and 2.6 l./m in./sq. m., re
spectively.
Significant differences (P < 0.05) in
arterial concentrations between the clearprime group and the hemodiluted group
are given in Table II. A similar compari
son between the clear-prime group and
the whole-blood group is given in Table
III.
.E III.— S i g n i f i c a n t

Variable

Before perfusion and
mid-perfusion
None

C omm ent

One purported advantage of the bubble
oxygenator is that, because it is primed
with a clear solution, the amount of whole
blood needed is greatly reduced. For the
initial priming this is true: no blood is
needed, compared with 2500 ml. for the
hemodiluted prime in the vertical-sheet
oxygenator. But to maintain steady pump
flows acceptable to us ( that is, to replace
blood and fluid lost from the intravascu
lar compartment), a mean of 1700 ml. of
whole blood needed to be added for the
five adults. During the perfusions with

D if f e r e n c e s in A r t e r ia l C o n c e n t r a t io n s B e t w e e n T w o G r o u p s U n d e r 
g o in g O p e n - H e a r t S u r g e r y

Clear-prime group greater
than whole-blood group

Clear-prime group less
than whole-blood group

Hemoglobin

None

0 2 content

None

pC02
Sodium

Day 3
None

Potassium
Calcium
Osmolality
Glucose

During perfusion
End of operation
None
Early perfusion to end of
operation
None

During perfusion

Day 2 and day 3 (a.m.)

N one

30 min. after perfusion
Early perfusion
Before perfusion and 30
min. after perfusion
End of perfusion and 30
min. after perfusion

None
None
None

Non-esterified
fatty acids
Total ketone
bodies
Lactate
Pyruvate
Growth
hormone
Insulin

Vol. 14

Early perfusion through
end of operation
Early perfusion through
end of operation
None
Early perfusion through
day 1 and day 2 (p.m.)
None
None
Day 2 (a.m.)
None

None
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hemodilution, a mean of 300 ml. was
added. So the volume of blood saved, for
equal length of perfusion, was approxi
mately two units (1100 ml.). Priming the
vertical-sheet oxygenator with whole
blood took an average of 3700 ml., with
another 600 ml. added during perfusion.
Patients perfused with the whole-blood
prime had an average chest drainage, un
til midnight, of 1950 ml., compared with
330 ml. and 850 ml. in the clear-prime
and hemodiluted groups, respectively.
Hence, for reasons not investigated, blood
clotting appeared to be better in the
patients after perfusion with the bubble
oxygenator.
Oxygen tension was not different in the
three groups of patients. Arterial oxygen
content was reduced for the remainder of
the operation when hemodilution was em
ployed, as compared with no dilution. This
points out the advisability (with hemodilu
tion) of maintaining an elevated Pa0 by
keeping the inspired concentration of oxy
gen at 40% to 50%. Hemoglobin and oxy
gen-carrying capacity again decreased on
the third and fourth days, probably due
to red-cell destruction and recurring hemo
dilution.
Patients perfused with the bubble oxy
genator did not become acidotic during
perfusion, possibly because THAM was
given with the non-fresh ACD blood added
to the oxygenator. After the operation, the
patients perfused initially with a clear
priming solution, and those perfused with
whole blood, experienced a greater degree
of metabolic alkalosis than did those per
fused with diluted blood.
Electrolyte behaviour in the three groups
was related to the differences between
primes. Hyponatremia was caused by both
primes involving hemodilution, and sub
normal plasma sodium concentrations were
seen after operation in all groups. Only the
diluted-blood prime, with THAM and
glucose, produced hyperosmolality during
operation. All three groups, including the
one that did not receive a fluid load during
operation, showed hypo-osmotic plasma by
the third and fourth days. This is probably
due to generalized retention of water by
the body,10 owing to increased activity of
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antidiuretic hormone11 and perhaps other
factors.
Regardless of plasma potassium level
during perfusion, frankly subnormal con
centrations are seen by the end of opera
tion and later in the day. During this
interval, a large loss of potassium occurs
by diuresis, and the hyperglycemia and
hyperinsulinemia may cause intracellular
movement of potassium.12 This period of
hypokalemia is known to be associated
with the development of ventricular ar
rhythmias. Supplemental potassium given
after operation has reduced the incidence
of this ventricular hyperirritability.13
The prime that required the addition of
calcium was the only one that was fol
lowed by elevated plasma levels, though
smaller amounts of calcium were added
during the perfusions with the bubble oxy
genator. Cardiac output was not measured
in the patients with hypercalcemia, and we
have no data relative to possible positive
inotropism from these levels of total cal
cium.
The characteristics of energy metabolism
depended largely on the amount of glucose
administered via the priming solution. The
group perfused with the clear prime in the
bubble oxygenator received the largest
glucose load. Even the patients perfused
with whole blood, who received no exo
genous glucose, had raised blood levels,
presumably from glycogenolysis and gluconeogenesis, but only to 165 mg./100 ml.
by the end of perfusion. This increase in
glucose concentration elicited only a slight
increase in the plasma insulin level, where
as high levels of the plasma insulin were
seen in the other two groups after termina
tion of hypothermia. Higher NEFA levels
were maintained during perfusion when a
glucose prime was not used, and without
the insulin response to inhibit NEFA mobi
lization serum levels of NEFA remained
higher than in the other groups through
the hours surrounding the end of opera
tion.
On the days after operation, arterial
NEFA concentrations were alike in all
groups, but, as evidenced by the ketonebody response, the rates of lipid utilization
were vastly different. The ketone bodies
accumulate in the blood when the liver is
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unable to metabolize NEFA as rapidly
as these acids are presented to it. Ketosis
was severe after the perfusions with the
clear prime in the bubble oxygenator and
moderate after the hemodiluted perfusion.
The pattern after perfusions with whole
blood was different—a gradual build-up
after operation. The patients subjected to
the greatest glucose loads (clear-prime
group) had no higher insulin responses
than did the other group that received
glucose in the prime ( hemodiluted group).
However, the clear-prime group had a
significantly greater degree of ketosis after
operation than did the hemodiluted group.
We also observed this relationship of the
degree of glucose load during perfusion to
the severity of the postoperative ketosis in
children.14 The explanation for this obser
vation is not apparent.
Lactate levels were highest after perfu
sion in the two groups that received the
largest glucose loads. The group of pa
tients perfused without glucose increased
their plasma lactate levels to 2y2 times that
of control before perfusion, with only a
small further increase during perfusion.
This group also showed the smallest in
crease in growth hormone, which can be
considered to be an indicator of the stress
response16 of the total organism. Although
there is evidence16 that insulin and growthhormone levels have an inverse relation
ship under certain conditions and a
sequential one in others, the levels of both
these hormones peaked between the end
of perfusion and the end of operation. The
insulin response was appropriate for the
degree of hyperglycemia. It is possible that
the magnitude of the stress response over
came the expected inhibitory effect of
hyperglycemia on growth hormone.
Su m m a ry

Six patients perfused with a clear prime
in a bubble oxygenator were studied dur
ing and after open-heart surgery. Arterial
and coronary sinus blood levels of oxygen,
acid-base parameters, electrolytes, energy
producing substrates, insulin, growth hor
mone, and cardiac output were determined
throughout anesthesia and for three subse
quent days. These six patients had higher
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blood glucose levels during operation and
greater metabolic alkalosis and ketosis
after operation than did patients studied
previously during the use of hemodilution
in the vertical-sheet oxygenator. Differ
ences between the clear-prime group and
a group perfused with fresh whole blood
were related to the presence, or absence,
of blood dilution. Patients perfused with
the clear prime in the bubble oxygenator
were subjected to more dilution of their
blood and to a greater glucose load.
Neither of the diluted primes seemed
superior from the aspects studied, but both
had advantages over whole blood.
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Resume
Les auteurs ont etudie six malades pendant et
apres une operation a coeur ouvert, ces malades
etant soumis a la perfusion d’une solution d'amorgage dans un oxygenateur a barbotage. Pendant
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toute la duree de l’anesthesie et pendant les trois
jours consecutifs a l’operation, ils ont mesure la
teneur en oxygene du sang arteriel et du sinus
coronarien, les perametres de l’equilibre acidebase, les electrolytes, les substrats energetiques,
l’insuline, l’hormone somatotrope et le debit cardiaque. Ces six malades presentaient une glycemie plus elevee pendant l’operation et une acidocetose plus forte apres l’operation que des malades
anterieurement soumis a une hemodilution dans
un oxygenateur a membrane verticale. Les dif
ferences constatees entre les malades recevant la
solution d’amorgage et ceux recevant le sang entier portaient sur la presence ou l’absence d’hemodilution. Les malades perfuses avec la solution
d’amorgage dans l’oxygenateur a barbotage avaient
une plus forte hemodilution et une charge plus
forte de glucose. Aucune des solutions hemodiluees ne semblaient presenter d’avantages au
point de vue des criteres etudies, mais toutes deux
presentaient des avantages sur le sang entier.

ERYTHROCYTE DYSFUNCTION IN SHOCK AND SEVERE ILLN ESS:
A STUDY O F THE HEMOGLOBIN OXYGEN-CARRYING CAPACITY AS A
CONTRIBUTING FACTOR IN REFRACTORY HYPOXIA"
E. F. G. BUSSE, M.D., F .R .C .S .[C ],f A. ZEKULIN, B.Sc. and
F. N. GURD, M.D., F.R .C .S.fC ], F.A.C.S., Montreal, Que.

T his paper presents a study of the oxygen
transport mechanism at the level of the
erythrocyte and its contained hemoglobin.
Systemic arterial hypoxia, which fails to
respond to oxygen administration, has be
come increasingly common in patients suf
fering from shock, sepsis, and other
extreme stresses. The current literature is
filled with studies directed towards the
analysis and correction of pulmonary in
sufficiency as the presumed basis for such
refractory hypoxia. We are fully aware of
the significance of ventilation-perfusion de
fects, of intrapulmonary shunting and
diffusion difficulties, but dissatisfaction
"From the McGill University Surgical Clinic,
Montreal General Hospital, Montreal 109, Que.,
and The Royal Edward Chest Hospital, Montreal,
Que.
fPresent address:
Sask.

Medical Arts Clinic, Regina,

Reprint address: Dr. F . N. Gurd, Department of
Surgery, Montreal General Hospital, Montreal 109,
Que.

with the standard explanations of cardio
pulmonary physiology led us to consider
that the actual capacity of the blood itself
to accept and transport oxygen might be
unfavourably affected in these patients.
The study reported in this paper was
designed to assess the ability of the blood
to react with, and to transport, oxygen. The
oxygen-carrying capacity of the blood of
12 seriously ill patients from the Intensive
Care Unit of the Montreal General Hos
pital was measured with particular refer
ence to the physical-chemical mechanisms
involved in oxygen transport. W e were con
cerned primarily with the hemoglobin
oxygen-carrying capacity (H O C C ), which
is defined as the maximal volume of oxygen
in cubic centimetres carried per gram of
hemoglobin in the patient’s blood at normal
pH, p C 0 2, and p 0 2 values. The value of
the HOCC is generally assumed to be a
constant of 1.34 c.c./g . and is treated as
such in many physiologic calculations. W e
observed wide variations of the hemoglobin
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oxygen-carrying capacity in severely ill pa
tients. The reporting of hemoglobin satura
tion as a percentage of normal should be
discouraged, because values greater than
100% reduce credibility. None the less, as
with the older conventions of reporting
hemoglobin content of the blood as a per
centage of normal, abnormally elevated
values are physiologically possible.
TAB LE I . — R e s u l t s

in

Maximal oxygen content.—An IL tono
meter* was used in which a 5-c.c. aliquot
of blood was suspended and allowed to
equilibrate for five minutes with a 4.5%
carbon dioxide-in-air gas mixture, which
was perfused through the apparatus at 100
c.c./min. at 37° C. The sample was im
mediately assessed for pH, p C 0 2, and p 0 2
using the IL Micro pH and Blood Gas

10 C o n t r o l P a t ie n t s a n d 12 ICU P a t ie n t s

Controls
Age
(years)

Sex

E.B.
A.Z.
M.W.
B.W.
P.Q.
J.G.
C.H.
G.B.
H.G.
G.P.

30
20
23
22
21
40
20
39
83
32

M
M
F
M
M
F
M
F
M
M

J.G.
A.M.
S.L.
B.F.
R.B.
A.L.
S.G.
M.M.
M.C.
M.G.
J.T.
W.M.

59
39
03
—
50
53
16
32
70
73
31
45

M
F
F
F
F
M
F
F
F
F
M
M

Initials

pO,

(mm. Hg)
—

pCO,
(mm. Hg)
—

—
110.0

pH
—

35.6

—
7.38

30.0
35.2
25.0
36.0

7.38
7.38
7.36
7.32

34.5

7.45

—

—

110.0
109.0
112.0
107.0
—

98.0

Ilh.
(g./lOO ml.)

Oxygen
content
(c.c.%)

HOCC
(c.c./g.)

14.4
19.9
1.38
14.2
1.34
19.1
1.32
12.5
16.5
16.5
21.7
1.32
21 .2
1.33
16.0
14.2
18.5
1.30
22.4
16.5
1.36
1.36
15.0
20.5
12.4
1.34
9.1
1.36
10.6
14.5
Mean Val ue of HOCG
1.34
Range
— 1.30-1.38

Patients From the Intensive Care Unit
—

—

—
—

—

112.0
110.0
110.0
97.0
112.0
104.0
106.0

35.0
35 .5
33.0
32.0
33.0
33.5
29 .5

M a t e r ia l an d M ethods

Tw o groups of individuals were studied:
the first group, 10 controls, comprised
normal volunteers and patients on the
wards of the hospital awaiting elective
surgery, while a second group consisted of
12 patients in the Intensive Care Unit
( I CU ) of the Montreal General Hospital
who were judged to be suffering from
severe traumatic, septic, or metabolic dis
orders. In each instance, venous blood
samples, drawn into heparinized syringes,
were analyzed according to the following
techniques.
Hemoglobin concentration. — The stan
dard clinical laboratory spectrophotometric
technique was used and results were ex
pressed in g.Hb./lOO ml. of blood.

—
—
—
—
—
7.43
7.41
7.42
7.42
7.37
7.48
7.40

13.1
12.7
11.6
13.8
6.8
11.5
12.6
12.8
12.9
14.6
12.0
10.2

14.8
18.4
16.5
17.2
8. 1
14.6
14.9
16. 1
19.5
18.3
17.7
19.7

1.13
1.45
1.42
1.25
1.19
1.22
111
1.26
1.51
1.24
1.47
1.90

Analyzing System Model IL-113-S2* ac
cording to the techniques outlined by the
manufacturer. The same sample was then
assessed for its total oxygen content using
a Thomas Van Slyke manometric apparatus
( Magnamatic m odelt) according to the
conventional techniques.
Assessment of the reaction rates between
the hemoglobin and oxygen.—In addition
to the parameters measured above and
using the same apparatus, in several
instances tonometry was performed for
different time intervals on different aliquots
of blood from the same patient and the
pH, pCOo, p 0 2, and oxygen content were
“ Instrumentation Laboratories, Boston, Mass.
i'Thomas Company, Philadelphia, Penn.
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determined. From these measurements, the was calculated by dividing the maximal
rate of reaction between the hemoglobin oxygen content by the hemoglobin con
and oxygen was assessed.
centration and expressing it in cubic centi
metres
of oxygen per gram of hemoglobin.
R esults
The data from the control group and from
The results of the measurements outlined the ICU patients are shown separately.
above are recorded in Table I, which in Not all measurements were made on every
cludes the value for the HOCC. This value case. Table II shows the data derived from
T A B L E II.—R esults op T onometry E x per im e n t s in F iv e C ontrol and S ix ICU P a t ie n t s

Tonometry
equilibra
Age
tion time
Initials (years) Sex (min.)
P.Q.
21
M
0
1
3
5
J.G.
46
F
0
1
3
5
G.P.
32
M
0
1
3
5
C.H.
M
26
0
1
3
5
G.B.
F
39
0
1
3
5
W.M.

45

M

M.G.

73

F

M.M.

32

F

M.C.

70

F

J.T.

31

M

W.M.

45

M

0
1
3
5
0
1
3
5
0
1
3
5
0
1
3
5
0
1
3
5
0
1
3
5

Controls

pO,
(mm. Hg)
—

70.0
108.0
110.0
28.5
51.0
109.0
110.0
14.0
43.0
98.0
98.0
33.0
57.0
112.0
112.0
24.0
47.0
106.0
107.0

pCO-z
(mm. Hg)
—

32.0
31.0
30.0
58.5
41.0
35.2
35.2
55.0
—
29.5
34 5
35 0
25.0
25 0
25.0
52.0
38.0
36.0
36.0

pH
—

7.39
7.38
7.38
7.28
7.38
7.38
7.38
7.35
7.46
7.45
7.24
7.40
7.38
7.36
7.28
7.34
7.34
7.32
—

Patients F rom the Intensive Care Unit
42.0
50.0
7.29
63.0
36.0
7.39
105.0
30.0
7 41
106.0
29.5
7.40
—

65.0
109.0
110.0
39.0
71.0
110.0
110.0
37.0
61.0
97.0
97.0
58.0
76.0
93.0
93.0
38.0
68.0
104.0
104.0

___

30 0
31.0
31.0
56.0
32.0
33.0
33.0
35.1
33.0
32.0
32.0
47.0
33.0
36.0
33.0
40.0
32.5
30.0

___

7.44
7.42
7.41
7.29
7.41
7.41
7.42
7.42
7.45
7.43
7.42
7.35
7.45
7.41
7.45
7.34
7.37
7 42

Oxygen
Hb.-O,
content
Hb.
content
(c.c.%) (g./lOO ml.) (c.c./g.)
—

19.2
20.7
21.2
6.8
14.5
17.7
18.5
—

10.2
14.5
14.5
10.8
18.4
21.9
22.4
6,1
14.2
19.7
20.5
9.9
11.8
15.5
19.6
_
17.9
17.9
18.3
9.6
13.8
14.2
16.1
9.8
18.8
19.5
19.5
11.8
13.5
15.3
16.5
6.2
11.5
19.8
—

___

___

16.0
16.0
16.0
14.2
14.2
14.2
14.2
10.6
10.6
10.6
10.6
16.5
16.5
16.5
16.5
15.0
15.0
15.0
15.0

1.20
1.29
1.33
0.48
1.02
1 .25
1 .30
0.10
0.98
1 36
1 .36
0.65
1 .12
1 33
1.36
0.46
0.94
1.31
1.36

10.5
10.5
10.5
10.5

0.94
1.12
1.48
1.85

14.6
14.6
14.6
12.8
12.8
12.8
12.8
12.9
12.9
12.9
12.9
11.4
11.4
11.4
11.4
10.2
10.2
10.2
10.2

1.23
1 23
1.25
0.75
1.08
1.11
1 26
0.76
1.45
1.51
1.51
1.04
1 . 18
1.34
1.44
0.61
1.12
1.94
—
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Fig. i.—Hemoglobin-oxygen content at various intervals of tonometry for the control and ICU

Fig. 2.—Plasma pO* at various intervals of tonometry for the control and ICU groups.
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Fig. 3.—The mean values for p02 and Hb.-02 content for the tonometry studies on the five con
trol patients are presented on the left and similar data for the patient M.M. on the right.

the tonometry experiments in which several
aliquots were equilibrated for different
time intervals in order to assess the rate
of the hemoglobin-oxygen (Hb.-Oa) re
actions; ICU patient W.M. was assessed on
two separate occasions.
In Figs. 1 to 3, the data from Tables I
and II are expressed graphically. Fig. 1
shows data from the tonometry studies for
the control group and the ICU patients.
The Hb.-Oa content is plotted against
time in each case; mean and range
values are indicated. For the control group,
the range of variability was narrow; the
five-minute maximal carrying capacity
mean value was 1.34 c.c./g. with a range
of 1.30 to 1.38. For the ill patients, the
mean value of the HOCC was similar, but
the range of values varied considerably.
Similarly we observed a wider range of
variability at the different time intervals.
In Fig. 2, when plasma p 0 2 is plotted
against time, the range of values for the

control group is again narrow, whereas
the range for ill patients is wider. Fig. 3
shows the relationship between the changes
of pOa and oxygen content after tonometry
equilibration for different time intervals.
The mean values for the control group are
shown and the values for a patient, M.M.,
compared. In the control group, there is a
relatively constant relationship between the
two parameters, each reaching a plateau
by the three-minute sample. In patient
M.M., there is a distinct delay in the rise
of the oxygen content of the blood, which
is accompanied by a more rapid rise in the
plasma p 0 2.
D isc u ssio n

General Considerations

The experiments reported above were
designed to assess the ability of different
blood specimens to react with and to trans
port oxygen. With the tonometry appar-
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atus, techniques of ventilation and inter
face exposure were standardized, hence,
variations among different specimens can
be ascribed to the specimens themselves.
Among the severely ill patients, there were
several patterns of variability. Some ap
peared to have an abnormality of the
HOCC. In general this capacity was re
duced, but in one patient it was exception
ally high. In some, there appeared to be an
anomaly in the relationship between the
pOa and oxygen content at different time
intervals in the tonometry studies.
In an attempt to analyze the reported
observations, we considered the physicalchemical phenomena involved in the up
take of oxygen by the erythrocyte under
two headings: first, the factors affecting
the reversible chemical reaction between
hemoglobin and oxygen; and second, the
physical-chemical phenomena affecting the
rate and extent of diffusion of oxygen into
and through the erythrocytes.
Factors affecting the reversible chemical
reaction between hemoglobin and oxygen —
With respect to the reversible chemical re
action between oxygen and hemoglobin,
Allen, Wyman and Smith1 and Schruefer
et air studied fetal hemoglobin first as free
hemoglobin and second as contained with
in the fetal erythrocytes. Both studies
demonstrated that the higher hemoglobinoxygen affinity of the fetal hemoglobin was
due to the electrolyte media in which the
hemoglobin was suspended, rather than to
specific differences in the hemoglobin it
self. These experiments demonstrated that
hemoglobin has a variable affinity for oxy
gen which is most sensitive to its electro
lyte environment. The Bohr phenomena, in
which the oxygen-hemoglobin affinity de
pends upon the hydrogen-ion concentra
tion of the media in which the hemoglobin
is suspended, further illustrates the sensi
tivity of the reaction between hemoglobin
and oxygen.3' 4
The biophysical characteristics of the
chemical reactions between hemoglobin
and oxygen were further delineated by
Rossi-Fanelli, Antonini and Caputo,5 who
studied the Hb.-02 reaction in different
solute suspensions and concentrations. They
showed that this reaction depends not only
upon the ionic strength of the media, but
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further, that it is sensitive to the type of
electrolytes in the media—different values
were obtained for reactions in a potas
sium from those in a sodium solution. Sommerkamp et al.tt confirmed the effect of
base excess and cation concentrations on
the oxyhemoglobin dissociation curve.
These demonstrations of the dependence
of the flb.-tb reaction upon the ionic con
centrations and character of the media can
be appreciated more clearly if one con
siders certain aspects of the hemoglobin
molecule. The protein moiety of the hemo
globin molecule has a high number of re
active carbamino loci with a high electron
resonance and, as such, is sensitive to the
ionic media in which it is suspended. The
stability of the protein moiety affects the
imidazol groups with which the oxygen
reacts; any variation in the electron reson
ance affects the strength of the imidazoleoxygen bond and, hence, the equilibration
point of the reversible chemical reaction.
As the electrolyte and hydrogen-ion media
in which the hemoglobin is suspended may
vary, the reactivity of the hemoglobin and
oxygen may also be affected. Surgenor4 and
Roughton3 have discussed these properties
of the hemoglobin molecule in detail.
The physical-chemical phenomena affect
ing the rate and extent of diffusion of oxy
gen into and through the erythrocytes —
The physical-chemical phenomena affect
ing the rate and extent of oxygen diffusion
control the supply of reactants and clear
ance of products of the oxyhemoglobin re
action and, hence, directly affect the ex
tent to which the reaction may take place
within the erythrocyte. The diffusion of
gases across the membranes of the erythro
cyte wall and through the hemoglobin mass
has been described by Forster.7 Factors
that may impair the diffusion rates include
the erythrocyte coatings, first described by
Bloch and Powell,8 and the aggregation of
erythrocytes into clumps, aggregates, or
rouleaux.9 In each instance, the surface
area of the erythrocyte membranes avail
able for diffusion is reduced with a pro
portional reduction in the diffusion rate.
When red cells aggregate, they reduce the
surface area:mass ratio of the hemoglobin
mass and impair the diffusion of oxygen
through the cell. With rouleau fonnation
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the relationship between surface area and
mass is such that when only five cells ad
here, oxygen diffusion is decreased by 50%,
which is approximately the maximal re
duction attainable. These changes affect
both the uptake of oxygen by the erythro
cytes in the lung and the release of oxygen
in the tissues. Roughton and Forster10
have presented evidence of the importance
of red cell resistance in diffusion and re
action rates.
Chemical reactions between hemoglobin
and oxygen are conducted as a “flow” pro
cess in which the time allowed for the re
action to come to completion is controlled
by the pulmonary circulation. Vogel,31 who
studied the blood flow in the lung capil
laries of the cat, attempted to calculate
the interface exposure time. His data indi
cate that the flow rate of 0.05 cm./sec.
allows an exposure time of approximately
0.1 seconds. Using Roughton’s values for
the reaction rates of hemoglobin in solu
tion and in dilute red cell suspensions,3
the half-time for the reaction between
hemoglobin and oxygen at 37° C. is 0.071
seconds in a 1 in 40 to 1 in 100 dilution
of whole blood. The time required for
equilibration of the Ilb.-CT reaction in the
alveolar-capillary interface is, therefore,
nearly the same as the interface exposure
time reported by Vogel. These data empha
size that both alveolar-capillary interface
exposure time and I lb.-C)2 reaction rates
may become critical factors limiting the
oxygen transport mechanism.
Since these studies were completed,
interest in hemoglobin oxygen-carrying
capacity as a factor in hypoxia has been
developing rapidly, and many different ap
proaches are now being exploited.12
Consideration of the Clinical Data
Many potential defects in the oxygen
carrying loading mechanism may be re
sponsible for the defects observed in the
clinical studies; however, one point deserves
particular emphasis: defects in the oxygen
transport mechanism do occur at the
erythrocyte level in the severely ill patient.
We have briefly reviewed the physicalchemical phenomena involved in the oxy
gen transport mechanism to draw atten
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tion to the sensitivity of the oxyhemoglobin
reaction to many influences and to the
complexity of multiple-stage diffusion re
actions. Intra-erythrocyte electrolyte levels
and the mechanism by which these are
maintained may have important influences
on the oxygen transport mechanism. This
mechanism is outlined by Passow.13 The
ability of ouabain to interfere with this
process is significant particularly since
many of our ill patients are digitalized.
The labile nature of the factors con
trolling the H b.-02 reaction suggests that
this component of the oxygen transport
mechanism is a potential point of failure
in the severely ill patient.
It should be clearly emphasized that the
factors described above may allow both an
increase and a decrease in the HOCC.
Neither an increase nor decrease from
normal should be considered advantageous,
because as the oxygen reactivity of hemo
globin is increased, the release of oxygen
at the peripheral tissues is impaired; and,
as the reactivity is decreased, oxygen re
lease is facilitated. The H b.-02 reaction
is a reversible chem ical reaction and is
governed by the many factors governing
such physiochemical reactions. A zone of
reactivity is defined as normal for normal
physiologic conditions, but physiochemically reactivity may vary in both direc
tions.
In instances of severe refractory hypoxia,
exchange transfusion with fresh erythro
cytes might be given to restore the oxygen
carrying capacity of the blood. Earlier
demonstration of an impairment of the
HOCC by the techniques outlined would
provide the indications for such an under
taking.
Summary

With more frequent determinations of
blood-gas values, arterial hypoxia has been
recognized more frequently as a physio
logic derangement in severely ill patients.
In certain of these patients there is no
direct support for the diagnosis of pulmo
nary ventilatory perfusion defects and they
remain hypoxic despite the administration
of oxygen in high concentrations.
The present study assessed the capacity
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of the blood of severely ill patients to re
act with and to transport oxygen. W e ob
served defects in the hemoglobin oxygen
carrying capacity ( H O C C ) and in the
normal relationship between the p 0 2 of
the plasma and the oxygen content of the
blood.
A brief review outlines some of the
current concepts concerning the factors
affecting the reversible chemical reaction
between hemoglobin and oxygen, and the
physical-chemical phenomena affecting the
rate and extent of diffusion of oxygen into
and through the erythrocyte. W e suggest
that the observed abnormalities of the oxy
gen transport mechanism might be ex
plained after a more thorough considera
tion of the basic physical-chemical re
actions involved.
The extent and severity of the reported
defects in erythrocyte function appear
capable of contributing significantly to the
refractory hypoxia so commonly seen in
the severely ill patient.
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R esu m e

Un recours plus frequent a la mesure des gaz
du sang a eu pour resultat de permettre de decouvrir plus frequemment le trouble physiologique qu’est l’hypoxie arterielle chez des malades
dont l’etat est critique. Chez certains de ces
malades, il n’existe aucun facteur susceptible de
confirmer le diagnostic d’anomalies de la ventila
tion
pulmonaire
et
meme
radministration
d’oxygene a forte concentration ne met pas fin
a l’hypoxie.
La presente etude avait pour objet devaluer la
capacite du sang des sujets tres malades de
reagir avec l’oxygene et de la transporter. Nous
avons note des anomalies dans la propriete de
l’hemoglobine de transporter l’oxygene et dans la
relation qui doit exister entre la p(.)= du plasma
et la teneur sanguine en oxygkne.
Dans une breve revue, nous avons rappele
quelques-unes des theories recentes sur les facteurs
qui entrent en jeu dans la reaction chimique re
versible entre l’hemoglobine et l’oxygene et dans
le phenomene physico-chimique qui affecte la
vitesse et l’6tendue de la diffusion de l’oxygene
au niveau du globule rouge. Nous estimons que
les anomalies constatees dans le mecanisme du
transport de l’oxygene pourraient etre expliquees
par un examen plus approfondi des reactions
physico-chimiques profondes qui sont en cause.
Les anomalies qui ont ete notees dans la fonction erythrocytaire, selon leur etendue et leur
severity, peuvent jouer un role important dans
l’hypoxie rebelle qui s’observe si souvent chez le
malade gravement atteint.
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TH E BATHTUB B U R N - A PEDIATRIC D ISA STER0
H. G. THOMSON, M.D., M.S., F .R .C .S.[C ],f and BEN SHORE, B.Sc., M.D.,
C.M., F .R .C .S .[C ],t Toronto, Ont.

were admitted to the Hospital for Sick
Children, Toronto, for primary therapy.
Scalds accounted for 50% of these ad
missions.13'15 Of this group, 93 children
sustained bathtub bums as a result of
sitting or falling into the tub with or with
out their clothes on. If initial treatment
was given in another hospital and the pa
tient was subsequently transferred to this
hospital, he was not included in this series.
In these 93 children, there was almost
equal distribution between male (48) and
female (45). The age range was 7 months
to 8 years. There were no children under
6 months of age. To calculate morbidity
and mortality, patients were separated into
Group A—under 24 months of age, and
Group B—over 24 months of age.
The average length of stay in hospital
for patients of both groups was 17 days,
suggesting that most of the bums were
first and second degree and had spontane
ously re-epithelialized. No patients in this
series required skin grafting. This fact
suggests that those infants and children
who died did so without extensive thirddegree burns.
Five patients in Group A and six in
Group B died—a mortality rate of 12%.
This compares with 3% to 4% reported in
other bum series involving all types of
burns.15 Of those children who died, the
average surface area burned was 45.6% in
Group A and 48.0% in Group B. The
average time of death after trauma was
seven to nine days in both groups. The
average time in Munro, Farmer and
M a teria l and M ethods
Csima’s series,15 which excluded bathtub
In the 20-year period, 1945 to 1965, 3195 and inhalation burns, was 28.9 days.
The combined LA 50 (lethal area) for
children with new bums from all causes
Groups A and B was 43% . Although our
rate is less than the 49.88% reported by
° From the Department of Surgery, The Hospital
Munro, Farmer and Csima13 and suggests
for Sick Children, Toronto, Ont.
a higher mortality rate with the involve
fPlastic Surgeon, The Hospital for Sick Children,
ment of a smaller area, the difference is not
Toronto.
statistically significant and may have been
^Resident in Plastic Surgery, The Hospital for
Sick Children.
owing to chance.
Reprint address: Dr. H. G. Thomson, Department
Necropsy, which was completed on eight
of Surgery, The Hospital for Sick Children, 555
of
the 11 children who died, showed the
University Avenue, Toronto 101, Ont.

A ccording to Artz and Reiss1 “the home
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rather than the workshop is the place
where bums are most likely to occur”, and
this opinion has been corroborated in large
“burn studies” in the United Kingdom and
North America.2’6 However, the continuing
emphasis on ignition and conflagration
burns relegates the bathtub burn to ob
scurity among the common scalds. Few
reports specifically mention the bathtub
bum.7 11 In 1968 Crikelair et al.,1'2 reporting
on a series of burns from all causes, noted
that of the four children who sustained
bathtub burns, one died. They emphasized
that the bathtub bum is a disastrous injury
and all medical practitioners should be
alert to its significance.
In the thermostatically-controlled electric
or gas-heated tank, the water temperature
is 130° to 160° F., hence, it is not surpris
ing that immersion for a short time at these
temperatures will cause death. Physicians
consider most scalds, including bathtub
bums, primarily first- and second-degree
burns which will spontaneously re-epithelialize. This is true if the patient lives
until re-epithelialization can occur. There
fore, death due to a bathtub burn is par
ticularly tragic because it is preventable,
its seriousness initially may be overlooked,
and the patient may not live for the 15 days
necessary for the burned area to re-epithelialize. The purpose of this paper is to
direct attention to the consequences of this
type of thermal injury, which has aroused
little concern to date.
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following changes: in four patients there
was apparent adrenal gland exhaustion
with antemortem hemorrhages; in five,
gastrointestinal
ulceration
(esophagus,
stomach, small and large bowel); in five,
septicemia
( hemolytic
Streptococcus,
Staphylococcus, Klebsiella and Pseudo
monas ).
These findings suggest that major com
plications occur much earlier and more
frequently in the child with a bathtub burn
than in patients with other types of burns.
For each patient who died, we attempted
to determine whether antibiotic therapy or
fluid replacement or both had been de
ficient. Five of these 11 patients were given
penicillin on admission and it was con
tinued in appropriate dosage for age. No
broad-spectrum antibiotics were used.
There was no apparent relationship be
tween antibiotic therapy and mortality.
The volume of parenteral fluid replace
ment for the first 48 hours was determined
on a retrospective basis using the Evan’s
formula as modified for children. These
volumes were then compared to those
volumes of replacement fluid actually
given. No relationship between parenteral
fluid underload or overload and mortality
was established. None of the patients re
ceived cortisone derivatives.

D iscussion
This study strongly suggests that chil
dren with a bathtub burn are more likely
to die and to die much earlier than chil
dren with other types of burns. The at
tending physician’s underestimation of the
initial area and depth of the burn surface,
and later inadequate parenteral therapy,
does not appear to have been a major factor
in the increased number of earlier deaths.
During the period covered by this study,
broad-spectrum antibiotics were relatively
unavailable or condemned for prophylaxis.
The high percentage of antemortem
adrenal changes and the frequency of
gastrointestinal ulceration suggest a more
severe acute stress reaction. The suspected
incidence of adrenal exhaustion is much
higher in this series than reported in the
general burn literature.16'18 However, it is
difficult to correlate accurately the evidence
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of microscopic adrenal exhaustion and
clinical adrenal insufficiency. It would be
better to anticipate this problem in this
particular type of burn by blood cortisol
levels and other laboratory investigations.
The pathologist reviewed paraffin sections
of the adrenal glands of the four patients
presumed to have had adrenal exhaustion
and reported that “The medulla and paramedullary areas of the zona reticulata show
intense congestion with focal microscopic
hemorrhage and both adrenal glands are
lipid-depleted. These adrenals are ap
proaching functional exhaustion but the
morphologic changes are not sufficient to
warrant a positive diagnosis of hypoadrenocorticalism. In one patient, one adrenal
gland was totally destroyed and the other
was approaching functional exhaustion.
These particular changes are slightly more
severe than similar changes in the other
three patients.”
Although these 11 children shared no
single common factor that could be at
tributed to their demise, this study suggests
that the child with a bathtub burn in an
involved surface area greater than 20%
should probably have early prophylactic
broad-spectrum antibiotics and cortisone
derivatives as supportive treatment. This
can be justified because of the more ex
tensive area of absorptive dermis that is
immediately exposed to all external influ
ences; the third-degree burn has its own
semi-protective envelope for at least two
weeks before these secondary problems
develop.

C onclusions
This study demonstrated that the bath
tub burn is potentially lethal; 11 out of
93 children with such bums died. These
patients need aggressive and early therapy
to prevent death and to permit re-epithelialization of the burned areas to occur in
15 to 20 days.

Summary
Ninety-three infants and children had
bathtub burns and 11 of them died. At
post mortem they had gastrointestinal
hemorrhages, evidence of adrenal exhaus-

tion, and septicemia. We believe that these
children should receive aggressive anti
biotic and cortisone therapy.
The authors wish to thank Dr. M. W ood, bio
statistician, and Dr. M. J. Lynch, pathologist, for
their assistance in the preparation of this paper.
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R esume
La signification clinique de la brulure par eau
bouillante ( dans la baignoire) > n’a pas pris tout
son relief par le fait qu’on l’a classee dans la
categorie des echaudures banales. Rares sont les
rapports qui mentionnenent ce type de brulure.
L ’objet du present article est d’ attirer l’attention
sur la nature inquietante de ce type de lesion.
Les auteurs passent en revue les histoires cliniques de 93 enfants qui ont ete hospitalises au
Hospital for Sick Children de Toronto, de 1945
a 1965. Cette etude retrospective a revele que la
mortalite a atteint 12% , le deces etant survenu
dans un delai de sept a neuf jours. La L A 50 com binee (region letale) a ete de 4 3 % . Chez quatre
des huit enfants qui sont decedes, on a constate
a 1’autopsie un epuisement des surrenales. On
n’a pas decouvert de relation entre la mortalite et
le remplacement liquidien par perfusion. Les
auteurs conseillent, dans ce type de brulure, de
recourir rapidement a des perfusions de remplacenient energiques et de prevoir le risque d’epuisement des surrenales.
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BENIGN LYMPHOID POLYPOSIS OF ILEUM: THREE CASES AND A
REVIEW OF THE LITERATU RE0
V. K. PATEL, M.B., B.S. and C. F. AW EN, M .D., C.R.C.P.[C], F.A.C.P.,t
Saskatoon, Sask.

I n 1966 Fieber and Schaefer1 reviewed
eight cases of lymphoid hyperplasia of
terminal ileum described in the literature
and reported four additional cases of thenown. The first case of lymphoid hyper
plasia of the terminal ileum was recognized
roentgenologically
and
presented
by
Marina-Fiol and Rof-Carballo in 1941
under the name “enteritis follicularis” .
The formation of discrete polypoid
lesions from the hyperplastic lymphoid
tissue o f the terminal ileum is a rare patho
logic process. Thomford and Greenberger2
in 1968 described a case of lymphoid
polypi o f ileum associated with Gardner’s
syndrome. In the same year Anthony3 re
ported a 10-year-old boy who, after re
current abdominal pain of eight months’
duration, underwent laparotomy. The re
sected terminal ileum showed hyper
plastic lymphoid polypi. In 1969 Keller4
described an asymptomatic patient with
benign nodular lymphoid hyperplasia of
small intestine involving duodenum, jejun
um and ileum.
Although several different terms have
been applied to these benign lymphoid
polyps, the term “benign lymphoid poly
posis” more clearly reflects the histopathology of the lesion. Cornes5 in 1961 called
the malignant counterpart of this lesion
“multiple lymphomatous polyposis” .
Symptomatic cases previously reported
were chiefly among young people who
ranged in age from 3*4 to 22 years;
asymptomatic cases appear to involve a
middle or older age group.
In this paper we wish to report three
asymptomatic cases of benign lymphoid
polyposis of the terminal ileum found incidently at autopsy.

C ase R eports

Case 1—A 64-year-old man was involved
in a car accident and sustained a rupture of
the gallbladder and a soft-tissue injury. He
died of bile peritonitis subsequently.
Case 2.—A 60-year-old woman sustained
multiple traumatic injuries in a car accident
and died from septicemia and pulmonary
embolism six weeks later.
Case 3.—A 58-year-old diabetic farmer, who
suffered from Shy-Drager’s syndrome, died
from massive pulmonary embolism.
In all three cases, the gross pathology
was more or less similar but histologically
there was some difference.
G ross Pathology

Case 1 had multiple small polypi in the
terminal ileum measuring from 0.1 cm. to
0.3 cm. in diameter. The polypi tended to
be sessile (Fig. 1). In Case 2 the polypi
were more slender and had delicate stalks.
The tips of the polypi were somewhat

* From the Department of Pathology, University
Hospital, University of Saskatchewan, Saskatoon,
Sask.
tDepartment of Pathology, Beilin Memorial Hos
pital, Green Bay, Wisconsin, U.S.A.

Fig. 1.—Close-up of the lymphoid polypi from
Case 1. The polypi tend to be sessile.
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supported by thick stalks and covered with
many microvilli. The terminal ends of the
polypi were clubbed. The stroma of the
polypi was invariably replaced by abun
dant lymphoid tissue, which often extended
to the mucosal layer of the polypus, obscur
ing the basic tissue architecture and form
ing secondary lymphoid nodules (F ig . 3 ).
The polypi ef Cases 2 and 3 revealed a
lesser amount of lymphoid tissue in the
stalk as well as in the tips of polypi ( Fig.
4 ). In Case 1, the stalk of the polypus and

Fig. 2.—Lymphoid polypi of Case 2. The polypi
are more slender and delicate. The tips of polypi
are somewhat clubbed.

clubbed (Fig. 2). Case 3 had polypi simi
lar to Case 2.
M icroscopic P athology

Even though gross pathology showed
somewhat similar polypi in all three cases,
histopathology revealed interesting differ
ences.
In Case 1, the multiple globular poly
poid structures were made up of hyper
plastic lymphoid tissue. These polypi were

Fig. 3.—A tissue section of the polypi showing
plump stalks and clubbed tips with many secon
dary lymphoid nodules. The mucosa between the
polypi is densely populated by lymphocytic ele
ments (H & E).

Fig. 4.—A tissue section of the polypi from
Case 2. The polypi are supported by delicate thin
fibrovascular stalks and the lymphoid nodules are
seen only in the tips.

adjacent normal mucosa were diffusely re
placed by abundant lymphoid tissue ob
scuring the mucous glands, while in Cases
2 and 3 the mucosa adjacent to the polypi
was fairly free from lymphoid tissue.
Another interesting difference was the
presence of mitotic figures found frequently
in Case 1 (Fig. 5) and infrequently in
Cases 2 and 3. The lesions in all three
cases showed eosinophils. Reticulum cells
showing large pink nucleoli were more fre
quent in Case 1 than in Cases 2 and 3.
Para-aortic and mesenteric lymph nodes
from Cases 1 and 2 were examined under
the microscope to determine if the process
of lymphoid hyperplasia was generalized.
However, these specimens did not reveal
any neoplastic or hyperplastic process.
D iscussion

These rare polypoid lesions of the small
intestine consist predominantly of lymphoid
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Fig. 5.—Microscopic features of the polypi dis
playing unusual numbers of reticulum cells. Five
mitotic figures could be seen in this chosen field
(H & E, original magnification X 480).

tissue with or without hyperplastic change.
The benign form of this lesion, “lymphoid
polyposis”, is pedunculated and has a
delicate fibrovascular stalk. According to
Cornes,8 the malignant counterpart of this
lesion forms in the mucosa and submucosa
as a mucosal thickening, as sessile and
pedunculated polyps, or as raised nodular
patches. Except for one case reported by
Keller4 and our three cases, both benign
and malignant forms appear to produce
symptoms. Three of the five patients re
ported by Cornes had radiologic evidence
of intestinal polyposis and the other two
were diagnosed at autopsy or laparotomy.
These patients suffered from diarrhea,
weight loss, tiredness and anorexia. In one
case reported by Nagle,6 small intestinal
lymphomatous polyposis was associated
with intussusception. Swartley and Stayman' reported a 7-year-old boy with
cramping lower abdominal pain who under
went appendectomy and ileotomy; micro
scopic examination of tissues showed
lymphoid hyperplasia.
Cornes8 in 1965 studied the number,
size and distribution of Peyer’s patches in
human small intestine and observed that
these patches were easily seen even in
elderly people. Some patches measured
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more than 4 cm. in length. Thus, lymphoid
tissue of small intestine seems to remain
functionally active despite the ageing pro
cess. Benign symptomatic lymphoid poly
posis usually involves young individuals,
and their lymphoid follicles are usually
large with prominent germinal centres.
In an 18-year-old youth reported by
Fieber and Schaefer,1 polypoid lesions in
some segments of the terminal ileum dis
played atypical lymphoid hypeiplasia, and
in others showed tissue change thought to
be a forerunner of lymphosarcoma.1 The
lesion in our first case also demonstrated
atypical features—a fair number of mitotic
figures and replacement of mucosa between
the polypi by dense lymphoid tissue con
taining abundant reticulum cells with
mitotic figures. Our first case and the case
reported by Fieber and Schaefer appear to
be premalignant. In fact, these authors
suggest that lymphoid hyperplasia may be
a precursor of “lymphoblastoma”. In our
cases, the lymph nodes collected from
mesenteric and para-aortic regions did not
have any atypical features.
The etiology of lymphoid polyposis is not
clearly understood. According to Helwig
and Hansen,9 the structure of the lymphoid
polyp suggests that the change is one of
hyperplasia. However, they did not elabor
ate on the pathogenesis any further. It is
possible that under infectious, immunologic
or other unknown stimuli, the lymphoid
tissue of the small intestine may undergo
hyperplastic polypoid changes. If pro
longed, such stimuli may convert benign
lymphoid polypi to their malignant counter
part—a lymphomatous polyposis—and this
lesion may pathologically appear as lymph
osarcoma, reticulum sarcoma or Hodgkin’s
disease. On gross examination, it may be
difficult to distinguish the malignant form
from the benign; however, the malignant
variety tends to be larger and appears as
sessile or raised nodular patches. The
regional lymph-node involvement or gen
eral nodal enlargement favours the po
tential or apparently malignant variety.
The benign fonn is usually small and in
variably pedunculated. When the benign
form produces symptoms and requires ex
cision, local resection appears curative.
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Su m m a r y

Three cases of lymphoid polyposis of the
terminal ileum are presented and the
literature is reviewed. Fifteen such lesions
were reported in the literature and all
except one produced symptoms. Our three
patients were middle-aged to elderly and
had no symptoms. Lymphoid polyposis
seems to be more common in men than
in women.
The lesions in one patient (Case 1)
showed histologic evidence of atypical
features. These atypical features suggest
possible early malignant transformation
progressing to multiple lymphomatous
polyposis.
The authors are grateful to Mr. John Junor for
the photographic preparation.
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R esum e
Les auteurs decrivent trois cas de polypose
lympho'ide benigne de Fileum, du reste asymptomatiques, qu’ils ont observes chez trois malades
d’age moyen ou avance. Le processus pathologique fondamental de ces polypes est une hyperplasie lympho'ide. Dans la phase benigne, ces
lesions sont petites et pedonculees: au point de
vue histologique, elles sont atypiques. Dans les
formes premalignes et malignes, les lesions sont
generalement plus etendues, sont sessiles ou se
presentent sous forme de plaques nodulaires surelevees. La presence d’une atteinte ganglionnaire,
regionale ou generalisee, augmente le i-isque d’une
forme maligne, notamment lymphosareome, sarcome a cellules reticulees ou maladie de Hodgkin.
La forme benigne, quand elle est symptomatique,
impose l’operation: la resection locale est curative.
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DETERMINATION OF INDIVIDUAL HUMAN TUMOUR SENSITIVITY
TO ANTITUMOUR AGENTS BY TISSUE-SLICE INCUBATION*
H. W. WILLOUGHBY, Ph.D.,
G. B. MAUGHAN, M.D., P. C. TREMBLAY, M.D.
and N. WOOD, B.Sc., Montreal, Que.
Selecting the most effective of several
types of antitumour agents for the treat
ment of an individual cancer often is diffi
cult on the basis of clinical experience
alone. A reliable and fast method for de
termining individual tumour sensitivity to
individual drugs would be of great value
in cancer therapy. Screening has been at
tempted using tissue or organ culture tech
niques,1-4 incubation of tumour tissue fol
lowed by estimation of enzyme levels5 and
incubation of tumour tissue with radio
active substrates.6' 7
This last method was used by Bickis and
Henderson,6, 7 who incubated tumour slices
for two horns in a medium containing
adenine and leucine (each labelled with
14C). To each experimental flask they
added an antitumour agent whose effec
tiveness was determined from the depres
sion of incorporation of these radioactive
compounds into ribonucleic acid (RNA),
deoxyribonucleic acid (DNA), and protein
fractions of the tissue, and the depression
of oxygen uptake during the incubation.
For our studies with human tumours,
we modified the procedure of Bickis and
Henderson6’7 omitting the oxygen uptake
determinations and using 14C-labelled
adenine and tritium-labelled L-leucine, i.e.
double labelling.
The studies outlined below were under
taken to assess the reproducibility of label
incorporation in replicate tumour-slice in
cubations in an attempt to ascertain
whether this method of screening human
tumours against assorted antitumour agents
could provide reliable guidelines for pa
tient chemotherapy.

°From the Department of Obstetrics and Gynae
cology, Royal Victoria Hospital, Montreal 112,
One.
tMedical Biochemist, Queen Elizabeth Hospital,
2100 Marlowe Avenue, Montreal 260, Que.
This project was supported by The John R. Fraser
Memorial Trust, McGill University.

M ethods

Seven tumour specimens were obtained
for this study; the individual diagnoses are
given in Table I.
Five to 20 g. of tumour tissue, obtained
at the time of operation, were carried im
mediately in ice-cold saline to the labora
tory, sliced with a Stadie-Riggs microtome,
and treated as described by Bickis and
Henderson except for the following altera
tion in the incubation and analytical pro
cedures:
(1) Krebs-Ringer bicarbonate (KRB)
plus glucose medium only was used, and
to each Erlenmeyer flask containing 3.0 ml.
of this medium we added 0.1 /xc. of adenine-8-14C and of L-leucine-4-5-T.
(2) Four control flasks were incorporated
in each tumour study, when the quantity
of tumour obtained was great enough, and
also two additional control flasks contain
ing dimethylsulfoxide (DMSO).
(3) Each determination with one drug
or drug combination was performed with
duplicate flasks and eight drugs or drug
combinations were tested with each tumour
if we had enough tumour tissue.
(4) The incubations were carried out
in Erlenmeyer flasks in a Dubnov shaker
in air for two hours at 37° C. rather than
in a Warburg respirometer.
(5) 0.5 N sodium hydroxide was used
to hydrolyze the RNA, then the DNA and
protein were precipitated by hydrochloric
and trichloracetic acids.8
(6) Aliquots of the RNA and DNA frac
tions were removed for colourimetric
analyses.9-10 After drying, these fractions
were dissolved in hyamine or N sodium
hydroxide for 14C estimation in a Packard
Tricarb scintillation counter, Model 3002.
The protein residues were dissolved in N
sodium hydroxide from which aliquots
were removed for colourimetric analysis11
and for tritium estimation in the same
counter. Various scintillation mixtures were

November 1971

407

INDIVIDUAL TUM OUR SENSITIVITY

TABLE I.—I nc or po ra tion

of

th e

RNA

DNA F r a ct io n s a n d T r it iu m in t o P r o te in F raction s
I ncubation in th e C o n t r o l F lasks *

and

1

2

3

4

Adenocarcinoma
of ovary

Adenocarcinoma
of ovary

Adenocarcinoma
unknown

Carcinoma
of
colon

Cases
Diagnosis

u C I nto

Carcinoma
of ovary

A

B

A

B

A

B

A

B

A

B

22,550
21,700
42,700
33,000

72,300
69,500
88,700
79,000

20,600
22,420
28,400
27,400

16,630
14,600
13,620
19,900

13,700
16,800
15,600
20,200

11,470
16,620
13,370
16,610

28,300
27,500
23,350
57,400

98,200
92,000
87,200
73,900

10,440
8,940
19,900
22,000

42,600
30,500
61,900
63,800

DMSO
Controls

3,770
2,580

10,700
8,000

12,300
13,760

9,160
8,790

15,650
10,450

7,350
12,470

1,130
475
1,170
1,205

14,420
3,800
9,680
9,770

1,140
1,610
1,4 0
2,250

4,600
5,750
4,600
7,580

240
445
340
560

1,420
2,870
2,4i5
3,145

210
150

1,840
1,427

455
610

1,835
2,325

195
190

1,275
1,385

Controls 120,500
Tritium into
130,000
295,000
protein
320,000
fractions

28,300
25,200
40,450
51,600

14,525
24,100
22,600
—

3,500
3,460
2,445
—

1,662
546

11,050
12,915

2,155
2,057

14C into
DNA
fractions
DMSO
Controls

DMSO
Controls

9,215
2,425

umour

T issu e S lic e s D u r in g

6

7

Carcinoma
oj ovary

Carcinoma
of
colon

A

B

11,240 43,000
26,800 274,000
11,340 47,900
—
—

A

B

35,450
20,930
—
'—

92,800
85,800
—
—

—

—

—

—

1,610
1,323

5,430
5,030

4,795
—

24,100
—

7,800
10,300
10,000
11,880

506
532
1,339
970

1,744
1,715
3,100
2,043

672
515
463
—

5,290
3,600
3,405
—

219
238

260
248

227
—

1,360
—

—

—

1,830
2,140
2,965
2,500

627
919
1,272
878

3,125
1,055
1,033

1,406
776
295

4,710
2,130
—

2,140
783
—

—

—

—

206
894

93
562

530
—

234
—

—

—

—

—

1,005
2,040
1,673
3,910

_

—

T

5

Controls
RNA
fractions

of

—

—

—

—
942
1,040
501
1,345

4,550
4,530
3,140
10,300

—
—

—
—

—

—

___

—

—

—

—

—

—

—

—

—

— .

—

1,362
592

4,760
2,265
—
—

—

—
—

—

*A = D/min./lOO g. wet weight of tissue: B = D/min./mg. of DNA, RNA or protein (specific activity).

R esults

used but corrections for quenching were
always carried out.
The drugs used in this study were: 1bis ( 2-chlorethyl) amino-l-oxo-2-aza-5-oxaphosphoridin ( Procytox); 2,3,5-triethyleneimino-l,4-benzoquinone (Trenim on); meth
otrexate; thiotepa; 5-fluorouracil; N-dichloroacetyl-DL serine (N a salt) (Blevid o n ); 17-ahydroxy-6a-methylpregn-4-ene-3,
20-dione acetate (Provera); NM-16° and
NM-38A,f in the doses per flask used by
TABLE

II.— A v e r a g e D

e v ia t io n s , a s

1

2

Cases
A

R N A ......................
D N A ......................
Protein..................

29.0
26.1
42.1

B

A

8.4
29.7
26.1

13.0
19.9
19.1

P ercentages

The counting data for the control flasks
are given in Table I as disintegrations per
minute (D /m in .) in the RNA, D N A and
protein fractions in 100 mg. wet weight
of tissue (A values in the tables), and as
specific activity, i.e. D /m in./m g. o f DNA,
RNA or protein in each incubation flask
(B values in the tables). The agreement of
the results obtained with replicate tissue
of th e

3
B

A

13.3 11.8
18.3 26. 8
14.7 —

M

eans, of th e

4
B

14.4
21. 8
—

Bickis and Henderson,7 except for the last
two drugs for which the doses were de
termined in rats with Walker 256 carcinoma
in our laboratory. The last three drugs are
insoluble in water, so appropriate doses
were dissolved in 0.2 ml. of DMSO, except
for Case 1 in which 0.4 ml. of DMSO was
used, which was incorporated in the
medium.
,,N M -1 6 -N -b is(2
chlorethyl)-2
benzamidopropionamide; Charles E. Frosst & Company, Mont
real, Que.
tN M -38A—the salt of Nor-nitrogen mustard and
naptholic acid; Charles E. Frosst & Company,
Montreal, Que.

A

B

3 4. 0
56. 0
41. 3

C ontrol V alu es

5
A

6. 6
11.0
24. 6

B

in

T

able

6
A

3 7 . 0 36.6
3 8. 0 22.0
15.8 18.8

7

B

42. 0
15.4
53.2

I

A

83.0
19.3
35.1

B

24.9 3.9
3 9 . 4 35. 5
3 7 . 7 46.4

incubations was poor. The average devia
tions of the control results, expressed as
percentages of the means (Table I I ), gave
a range from 11.8% to 56% for the A
values, and from 6.6% to 83% for the B
values.
In the results from the duplicate DMSO
flasks, in spite of the very poor agreement
in two of the 12 pairs of results in Table
I, we can conclude that the incorporation
of labelled substrates was markedly re
duced.
When the results from the incubations
for single or combined drugs were ex
amined, in 29%, 14% and 36% o f the
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duplicate A results, and in 22%, 12% and
27% of the duplicate B results (as A and
B above), one result was more than twice
its duplicate. Thus, some improvement in
agreement was noticed when the counting
data were expressed as specific activities.
A statistician consultant commented that
these data showed such poor agreement
that a more elaborate evaluation of them
would only be a waste of time; they have
not been included in this paper.
D iscussion

The omission of the determinations of
oxygen uptake and carbon dioxide produc
tion allowed us to increase the numbers of
incubation flasks. Bickis and Henderson0’ 7
probably were limited by the number of
determinations that can be done in a War
burg incubator and thus did two, or oc
casionally three, replicate control flasks
while we were able to do four replicate
control flasks. Also, we were able to do
duplicate determinations with each drug
if enough tissue was obtained from the pa
tient, while those authors were limited to
a single flask for each drug. Thus, we
were able to examine this procedure more
minutely for reproducibility.
From the data in Table I it is obvious
that the agreement of the values from
replicate flasks was so poor that reliable
control incubation values could not be ob
tained. Standard deviations, as percentage
value of the averages of replicate deter
minations are greater than 25% in 14 of
the 20 values reported in Table II. The
spread is reduced when the B values are
examined similarly; only nine of the 20
average deviations fell above 25%. The
results for the pairs of drug flasks men
tioned above were equally discouraging
and we are forced to conclude that, in our
hands, this method gave results whose
reproducibility was so poor that it is use
less as a guideline for cancer patient
chemotherapy.
It is possible that the poor agreement
could be due to variation in cell type in
the tissue added to each flask. Human
tumours often contain more than one type
of cell and the proportion of each type
present in a tissue slice could vary from
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slice to slice even though the tissue was
grossly similar in each slice. Also, necrosis
may vary in tumour tissue and, if present
in small scattered pockets of cells, would
not be detected by visual examination. As
the tissue slices were completely destroyed
in the procedure, we could not examine
the slices microscopically to determine
homogeneity of the tissue. Tchao et al
in their organ culture studies with human
tumour tissue, reported marked variations
in different cell populations in adjacent
slices from the same tumour.
The only positive finding in this study
was that DMSO, either 0.2 ml. or 0.4 ml.
in 3.0 ml. of medium, lowered the incor
poration of 14C and tritium into nucleic
acids and protein respectively. The recent
finding that DMSO, 2% in the medium,
strongly inhibited the growth of HeLa cells
and, 12% in the broth, inhibited the
growth of E. coli, supports our findings.12
Some success in determining the sensi
tivity of human tumours to individual anti
tumour agents has been achieved by
culture methods including tissue culture,2 4
organ culture5’ 13 and rooster plasma clot
cultures.14,15 The determination of drug
sensitivity was based on morphologic dam
age of tissue determined microscopically
and this approach promises more success
than the incubation procedure we followed.
C onclusions

The reliability of the incorporation of
labelled adenine and L-leucine into nucleic
acids and protein has been investigated.
Replicate results obtained with this tech
nique showed such poor agreement that
no recommendations for patient therapy
could be made.
Dimethylsulfoxide lowered the incorpora
tion of these metabolites into tissue com
ponents.
We wish to thank Dr. I. Horowitz of the De
partment of Epidemiology and Public Health,
McGill University for his statistical appraisal of
the data we obtained in this study.
The experimental drugs were provided by
Charles E. Frosst & Company, Montreal, Que.
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R esu m e
Les auteurs se sont servis d’adenine et de
leucine marquees qu’ils ont incorporees aux acides
nucleiques et aux proteines pendant l’incubation
de la tranche tissulaire, pour evaluer Faction des
antitumoraux sur les tumeurs humaines individuelles. La repetition de Fincubation avec des
tranches de la meme tumeur a donne des con
cordances entre metabolites marques tellement
mediocres qu’on ne pouvait se servir de ces
donnees comme guide pour le choix de la chimiotherapie a appliquer au malade. L ’addition de
dimethylsulfoxyde (D M SO ) au milieu d’incubation a reduit l’incorporation de ces metabolites
marques dans les tranches tissulaires.
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EXTR A D U R A L METASTASIS FROM A PRESUM ED CAROTID-BODY
TUMOUR PRODUCING PARAPLEGIA: A CASE REPORT
D. N. GONGAL, B.Sc., M.B., M.S., F.I.C .S.,* GORDON J. MACK, M.D.,
F.R .C.S.[C], F.A.C.S.f and B. B. VAIDYA,| Kathmandu, N epal
T h e surgical management of carotid-body
tumours carries a significant serious mor
bidity and mortality. One important con
sideration in the decision to operate is
whether the tumour is to be considered
benign (admittedly with local potential of
fatal complications) or malignant. Only a
few confirmed cases of distant metastasis
have been documented and these have
been collected in the excellent reviews of
Morfit, Swan and Taylor,1 Hendrick,2 and
Westbury.3
C a se R ep o r t

S.S.P., a 34-year-old man from East Nepal,
was admitted on June 30, 1969, in critical
condition with paraplegia of one year’s dura
tion, severe urinary tract infection and de
cubitus ulcers. There was no history of trauma.
He was managed, within the limits of our
facilities, on a hospital-made “Stryker” frame,
and with bladder training; eventually the
ulcers were covered with rotation flaps and
skin grafting.

Fig. 1.—The tumour in the left anterior superior
cervical triangle was three inches in diameter and
had been present for five years.
'Senior Staff Surgeon, Bir Hospital, Kathmandu,
Nepal.
JSenior Surgeon, Shanta Bhawan Mission Hos
pital, Kathmandu.
^Pathologist, Military Hospital, Kathmandu.

An almost incidental finding, considering
the patient’s desperate condition, was a firm
non-tender oval tumour in the left anterior
superior cervical triangle; three inches in
diameter, it transmitted pulsation and had
been present for five years (Fig. 1 ). His
cerebrospinal fluid was clear, scanty and at low
pressure indicating a proximal block. It
showed only a trace of protein with five cells.
The V D R L test was negative. Radiographs of
the chest and thoracic spine were negative,
but a myelogram, when dye was eventually
obtained,- revealed a complete block at the
level of T7.
Following at least partial control of his lifethreatening complications and elevation of his
hematocrit from 28% to 39%, a laminectomy
was performed under general anesthesia, un
covering T5, T6 and T7. A soft pale welldemarcated dorsal extradural soft-tissue tumour
was exposed which peeled easily from the
dura. On opening the dura, no further ob
struction was encountered to an exploring
catheter.
On gross examination, the pathologist de
scribed “a smooth greyish firm tumour meas
uring 2 x 1.5 x 1 cm. There is evidence of
bony erosion by tumour.” Histologically it was
reported “Tumour shows nests of large poly
hedral cells with rounded nuclei arranged in
alveolar pattern and separated from each other
by connective tissue and vascular stroma. This
is consistent with secondary from primary
carotid-body tumour.” (Figs. 2 and 3 ). A later
supplementary report of the biopsy of the
decalcified lamina did not confirm the gross
appearance. The pathologist added “no evi
dence of secondary carotid-body tumour.
Necrotic foci are probably pressure necrosis.”
Following Swan’s policy, we had the slide
reviewed by an independent pathologist. He
reported “The morphology of the lesion is
typically that of a chemodectoma or para
ganglioma, and as such could be a carotid-body
tumour. While not histologically malignant it
has obvious bone within the tumour and
hence fits a vertebral metastasis. In interpret
ing a case of this kind it is imperative to know
that there is not one or more chemodectomas
in the neck, thorax, or abdominal retroperitoneum.”
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D iscussion

Fig. 2.—Low-power view of the tumour. Note
the arrangement of anaplastic cells in solid ball
like masses penetrated by a capillary network.
Larger fibrous septa are also seen (H & E, original
magnification X 60).

In Morfit, Swan and Taylor’s compre
hensive review,1 they found one previous
case of metastasis to the thoracic vertebrae
(T5 and T 6), and added one of their own
proved at autopsy. Westbury:i described a
man with a 20-year history of tumour who
had a local metastasis removed and con
firmed, then six months later became para
plegic with a lumbar-spine deposit diag
nosed at autopsy as “metastasizing carotidbody tumour”.
Our case has several obvious deficiencies.
The cervical tumour was never identified
pathologically. Once afebrile, with his
ulcers healed, although his neurologic state
was unimproved, the patient returned with
his family by stretcher to a remote area of
the country completely lacking in medical
care, where he has probably now suc
cumbed to paraplegic complications—with
out an autopsy.
The presumptive evidence for metasta
sizing carotid-body tumour producing
paraplegia is sufficiently strong, however,
to warrant recording this case report.0
Su m m ary

A 34-year-old man was admitted to hos
pital with paraplegia, urinary tract infec-

Fig. 3.—Higher power view of the tumour. The
tumour cells are small with darkly stained round
or ovoid nuclei and relatively abundant palestaining cytoplasm. In the lower right of the
micrograph, the stroma is homogeneous, hyalinized and resembles amyloid (H & E, original
magnification X 350).

“ Editor’s note. Pathologists who reviewed this
paper concluded that the sections represented
metastatic carcinoma of the thyroid. A consultant
described the section in the following terms: “ The
tumour is highly cellular and characterized by
nests and masses of anaplastic small round or
ovoid cells with staining cytoplasm (Fig. 2 ). The
tumour cell nuclei are hyperchromatic. There is
little cellular pleomorphism. The stroma between
the cell masses is rich in capillaries. Fibrous tra
beculae traverse the lesion. In some areas the
stroma is brightly eosinophilic, hyalinized and
suggestive o f amyloid (Fig. 3 ).” H e drew the
following conclusions about the source of the
tumour: “ From the structure of this tumour and
its location, there is no doubt that this lesion is
a metastatic carcinoma. The histogenesis of the
tumour is not certain. Origin from a carotid-body
tumour is possible but spread from a medullary
carcinoma o f the thyroid would be more likely,
in my opinion. T o confirm this view, it would be
necessary to find a primary tumour in the thyroid
or to demonstrate amyloid fibrils in the tumour
and the specific granules within the cytoplasm of
the tumour cells. In a recent case o f this type
at the Toronto General Hospital, the diagnosis of
medullary carcinoma was established with cer
tainty only after amyloid fibrils and cytoplasmic
specific granules were demonstrated by electron
microscopy.”
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tion and decubitus ulcers. During treat
ment, we found a firm non-tender threeinch tumour in the left superior cervical
triangle; it had been present for five years.
At laminectomy, a soft well-demarcated
dorsal extradural tumour was removed
without complication. On gross examina
tion, the appearance of the tumour was
consistent with a secondary from a primary
carotid-body tumour, but this was not
confirmed by biopsy of the decalcified
lamina. However, a report by an independ
ent pathologist led us to believe that this
patient’s paraplegia was probably caused
by a metastasizing carotid-body tumour.
The authors wish to thank Dr. M. J. Phillips,
Department of Pathology, Toronto General Hos
pital, for his help in preparing this paper for
publication.
R eferences
1. Morfit HM, S wan H, T aylor ER : Carotid
body tumours; report of twelve cases in
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cluding one case with proved visceral dis
semination. Arch Surg (Chicago) 67: 194,
1953
2. Hendrick JW : Carotid body tumours. Sur
gery 31: 385, 1952
3. W estbury G: Management of carotid body
tumours; with report of seven cases. Brit
J Surg 47: 605, 1959
R esu m e
Un homine de 34 ans ete hospitalise pour
paraplegie, infection des voies urinaires et ulceres
de decubitus. Pendant le traitement, nous avons
decouvert dans le triangle cervical superieur
gauche une masse ferine de trois pouces de
longueur qui y etait presente depuis cinq ans.
Au moment de la laminectomie, nous avons
excise sans complication une tumeur dorsale
extradurale, molle, bien delimitee. A l’examen
macroscopique, la tumeur donnait a penser qu’elle
etait secondaire a une tumeur primaire du glomus
caroticum, mais cette hypothese n’a pas ete con
firmee par la biopsie de la lame decalcifiee.
Cependant, un rapport foumi par un pathologiste
independant a porte les auteurs a croire que la
paraplegie dont souffrait le malade avait ete
probablement causee par une tumeur metastatique du glomus caroticum.
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IMPROVED ATTACHMENT FOR STEINMANN-PIN TRACTION
R. L. AILSBY, B.Sc., M.D.,** Saskatoon, Sask.
S
traction applied through a Steinmann pin is a successful method of manag
ing certain fractures.1'3 The usual method
of attaching this has been by a stirrup
arrangement. We believe that this is not
entirely ideal because (1) the pin may ro
tate in the bone as a result of friction be
tween the stirrup and the pin clamp; (2)
the single rope attached to the stirrup inter
feres with the foot; and (3) the stirrup
may place unequal stress on the ends of
the pin if the traction rope is not at right
angles to the pin.
keleta l

0
Fig. 2.—The component parts of a single
attachment.

We have developed an attachment which
incorporates a minimal-friction bearing
with a stabilizing traction arm (Figs. 1
and 2). Over the last two years, by using
two of these light highly mobile attach
ments placed at the ends of the protruding
threaded Steinmann pin, and by applying
traction directly to these attachments, we

Fig. 1.—Anteroposterior view of the assembled
single attachment.
“Department of Orthopedic Surgery, University
Hospital, University of Saskatchewan, Saskatoon,
Fig. 3.—Close-up view of the leg of a patient
Sask.
with two attachments and cords.
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have achieved effective skeletal traction
(Fig. 3). In addition, this improved design
has the following advantages: (1 ) even
and equal traction can be applied to both
ends of the pin and an even pull main
tained in the desired plane no matter in
what position the patient places his limb;
(2 ) minimal binding between the pin and
traction arm allows movement of the area
under traction with no rotatory or angulatory stress on the pin. This in turn reduces
movement of the pin in the bone to near
zero and reduces the pain and risk of in
fection at the pin site; (3) two-point attach
ment allows the traction ropes to remain
clear of the limb distal to the traction site;
and (4 ) the almost frictionless movement
obtained by this method greatly facilitates
active physiotherapy.
This attachment incorporates a steel ball
bearing0 and modified low-friction nylonf
(replaceable) bearing in a stainless steel
hub. The attachment, which is firmly held
to the Steinmann pin with a machine set
screw, can be disassembled easily for
cleaning and changing of the bearings if
necessary. The bore of the attachment
allows it to fit firmly to any size Steinmann
pin. There is an exchangeable arm on the
mobile section of the apparatus for trac
tion-rope fixation.
The apparatus permits greater mobility
and fewer complications (pin bending and
pin movement) in three ways: (1 ) reduced
friction, (2 ) application of balanced pin
torque, and (3 ) clearance of the foot from
rope interference.
As pointed out above, the key to this
improved traction is its mobility and torque absorbing qualities due to the low-friction
“Standard grease-sealed ball-bearing (machine
quality) S.K.F. type.
tStandard type 7 Snap in Nyliners; Thompson
Industries— Dupont Nylon.
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bearing. In certain instances (Russell trac
tion),2 a stirrup attachment is still needed
and these bearings are incorporated into
the ends of the classical stirrup.
Su m m a r y

We have found this method of traction
especially useful in fractures requiring
tibial (fractured femur) and calcaneal
(tibial fracture) traction. The apparatus
permits an earlier and a more active level
of physiotherapy with the resultant earlier
pain-free knee movement and quadriceps
maintenance. We therefore recommend
traction with this mobile attachment in the
management of selected fractures.
I wish to thank Mr. Hans Dommasch of the
Medical Photography Department, University of
Saskatchewan, for his help and advice.
R eferen c es

1. P e r k in s G: Fractures and Dislocations, Lon
don, Athlone Press, 1958
2. R u s s e l l RH: Fracture of femur; clinical
study. Brit J Surg 11: 491, 1924
3. S t e in m a n n F : Zur Geschichte der Nagelextension. Z Orth Chir 29: 96, 1911
R esum e
Toute traction effectuee sur un clou de Stein
mann risque de provoquer plusieurs complications.
Le present article decrit un appareil qui permet
de n’appliquer la traction qu’aux niveaux desires
et qui reduit le pliement du clou, ses rnouvements et l’infection au niveau de l’insertion du
clou dans les tissus.
Le nouvel appareil comporte un petit roulement, tres leger, virtuellement exempt de friction
et qui absorbe le couple de torsion. II est contenu
dans un moyeu qui se fixe facilement aux extremites saillantes d’un clou de Steinmann. Cette
methode de traction nous a permis de reduire
sensiblement les complications au niveau du clou.
Elle presente un grand interet dans le traitement
des fractures des membres inferieurs qui exigent
une traction sur le tibia ou le calcaneum. Grace a
cet appareil, il est possible de commencer rapidement des traitements physiotherapiques actifs et
de les poursuivre activement, prevenant de la sorte
l’atrophie musculaire et la raideur articulaire.
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T H E C A N A D IA N JO U R N A L OF SU RG ERY
All communications concerning this journal
should be marked “The Canadian Journal of
Surgery” and addressed to the Editor, 530
Scarlett Road, Suite 1002, Weston 626, Ont.
The Journal is published bi-monthly. Sub
scription is $15 per year ($7.50 per year for
trainees in surgery), and starts with the Janu
ary issue of each year. Single copies are $2.50
each, payable in advance. (It would be greatly
appreciated if subscribers would add bank ex
change to their cheques.)

INSTRUCTIONS TO CONTRIBUTORS
Manuscripts
Manuscripts in duplicate of original articles,
case reports, and other contributions should
be forwarded with a covering letter re
questing consideration for publication in The
Canadian Journal of Surgery. Acceptance
is subject to the understanding that they
are submitted solely to this Journal, and
will not be reprinted without the consent
of the author and the publishers. Accept
ance or rejection of contributions will be
determined by the Editorial Board. As
space is available, a limited number of
case reports will be published. Articles
should be typed on one side only of un
ruled paper, double-spaced, and with wide
margins. The author should always retain a
carbon copy of material submitted. Every
article should contain a summary of the
contents. The Concise Oxford Dictionary
will be followed for spelling. Dorland’s
Illustrated Medical Dictionary will be fol
lowed for scientific terminology. The Edi
torial Board reserves the right to make the
usual editorial changes in manuscripts, in
cluding such changes as are necessary to en
sure correctness of grammar and spelling,
clarification of obscurities or conformity
with the style of The Canadian Journal of
Surgery. In no case will major changes be
made without prior consultation with the
author. Authors will receive galley proofs
of articles before publication, and are asked
to confine alterations of such proofs to a
minimum.
Reprints
Reprints may be ordered on a form which
will be supplied with galley proofs. It is
important to order these before publication
of the article, otherwise an extra charge
for additional type-setting will be made.

References
References should be referred to by numer
als in the text. They should include in
order: the author’s name and initials in capi
tals, title of the article, abbreviated journal
name, volume number, page number and
year. The abbreviations of journal names
should be those used in Index Medicus.
References to books should include in order:
author’s name and initials, title of book,
number of edition (e.g. second e d .), city
of publication, title of publishing house,
year of publication, page number if a
specific reference. For examples, see this
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white
illustrations will be reproduced free with
the articles. Colour work can be published
only at the author’s expense. Photographs
should be glossy prints, unmounted and
untrimmed, preferably not larger than 8"
x 6". Prints of radiographs are required
and not the originals. The magnification of
photomicrographs must always be given.
Photographs must not be written on or
typed on. An identifying legend may be
attached to the back. Patients must not be
recognizable in illustrations, unless the
written consent of the subject for j ublication has been obtained. Graphs anu dia
grams should be drawn in India ink on
suitable white paper. Lettering should be
sufficiently large that after reduction to
fit the size of the Journal page it can still
be read. Legends to all illustrations should
be typed separately from the text and sub
mitted on a separate sheet of paper. Illustra
tions should not be rolled or folded.
Language
It should be clearly understood that con
tributors are at full liberty to submit
articles in either English or French, as they
please. Acceptance will be quite independ
ent of the language of submission. If the
contributor wishes, he may submit an in
formative summary of not more than 300
words in the language other than that in
which he has submitted the article. For
example, an article in English must carry
an English summary and may, if the author
wishes, carry a more detailed summaiy in
French.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal
devra porter la mention “Le journal canadien de
chirurgie” et etre adressee a l’Editeur, 530
Scarlett Road, Suite 1002, Weston 626, Ont,
L e journal est publie a tous les deux mois. Le
prix de l’abonnement est de $15. par an ($7.50
par an pour les medecins qui sont residents en
chirurgie) et commence avec le numero de
janvier de chaque annee. Un exemplaire isole
coute $2.50 et est payable d’avance. (Nous
serions reconnaissants aux souscripteurs de vouloir bien ajouter a leur cheque le montant des
frais bancaires eventuels).
INSTRUCTIONS A NOS
COLLABORATEURS

Manuscrits
Les manuscrits d’articles originaux, de rap
ports cliniques etc. seront envoyes en deux
exemplaires, accompagnes d’une lettre deman
dant qu’on veuille bien considerer leur publica
tion dans L e journal canadien d e chirurgie. Ils
ne seront acceptes qu’a la condition qu’ils
n’aient ete soumis qu’a notre Journal et qu’ils
ne soient pas reimprimes sans le consentement
expres de l’editeur et l’auteur. L ’acceptation
ou le refus des articles soumis releve du Conseil de la publication. Si la place est disponible,
un nombre limite d’histoires cliniques pourront
etre publies. Les articles seront dactylographies
sur un seul cote d’un papier non ligne, a double
espace et avec une large marge. L ’auteur devra
toujours conserver une copie au papier carbone
du texte soumis. Tout article devra etre accompagne d’un resume. L’orthographe sera
celle adoptee par le dictionnaire Larousse.
Quant a la terminologie scientiflque, elle sera
basee sur le Dictionnaire des termes techniques
de medecine ou tout autre ouvrage de refe
rence serieux. Le Conseil de la publication se
reserve le droit d’apporter au texte les changements qu’il jugerait a propos pour assurer la
correction grammaticale et Torthographe, pour
eliminer d’eventuelles obscurites ou pour rendre la presentation conforme au style du Jour
nal canadien d e chirurgie. Aucun changement
important ne sera apporte au texte sans que
Tauteur ait ete prealablement consulte. Les
auteurs recevront avant la publication des
epreuves d’imprimerie de leur texte, auxquelles
ils sont pries d’apporter le minimum de correc
tions.
Tires-a-part
On pourra commander des tires-a-part sur
une formule qui est envoyee avec les epreuves.
II est important de les commander avant la
publication de l’article, sous peine de devoir
payer un supplement pour une nouvelle com
position.

Bibliographic
Les references bibliographiques seront indiquees par des numeros dans le corps du texte.
Elies comprendront dans 1’ordre: le nom de
1’auteur et ses initiates, en majuscules, le titre
abrege du Journal, le numero du volume, le
numero de la page et l’annee. Les abreviations
admises pour les noms de revues sont celles qui
figurent dans I’ln dex M edicus. Les renvois aux
livres comprendront dans l’ordre: le nom de
Tauteur, ses initiales, le titre de l’ouvrage, le
numero de l’edition (p. ex. deuxieme ed.), la
ville et le nom de la maison d’edition, et
l’annee de la publication; enfin, le numero de
la page s’il s’agit d’un renvoi precis. Pour
examples, voyez Tissue de janvier 1971 et ceux
a venir.
Illustrations
Le journal accepte de publier gratuitement
un nombre raisonnable d’illustrations en noir
et blanc. Les reproductions de cliches en eouleurs seront publiees aux frais de Tauteur. Les
photographies seront imprimees sur papier brillant, ne seront ni montees ni calibrees et d’un
format maximum de 6" x 8". En ce qui concerne les radiographies, nous demandons des
copies et non pas Toriginal. On devra toujours
fournir un agrandissement de microphoto
graphies. Il ne faut jamais ecrire ou dactylographier un texte quelconque sur les photo
graphies. Une legende les identifiant pourra
etre jointe au dos. Dans les illustrations montrant des malades, ceux-ci ne pourront etre
reconnus, a rnoins qu’ils n’en aient donne le
consentement ecrit prealablement a la publica
tion. Les graphiques et diagrammes seront dessines a l’encre de Chine sur un bon papier a
dessin blanc. Le lettrage devra etre ecrit en
caracteres assez grands pour que, apre reduc
tion proportionnelle au format du Journal, ils
soient encore lisibles. Les legendes devant
accompagner les illustrations seront dactylo
graphies sur une feuille independante du
texte. Les illustrations ne seront ni roulees ni
pliees.
Langue vehiculaire
II doit etre clairement etabli que les collaborateurs ont pleine liberte de soumettre leurs
articles en frangais on en anglais, a leur choix.
L ’acceptation de l’article sera entierement independante de la langue choisie par Tauteur. Si
le collaborateur le desire, il peut decrire le
contenu de Tarticle en un sommaire ne depassant pas 300 mots et dans une langue differente
de la langue choisie pour Tarticle lui-meme.
Par exemple, un article ecrit en frangais doit
comporter un resume en frangais et peut, si
Tauteur le desire, etre accompagne d’un som
maire plus detaille en anglais.
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BOOK REVIEWS
ANESTHESl

FOR TUE AGED. Paul H . Lorhan . JS:J pp . C harles C Thomas Publisher,
S11ri11glleld Ill ,; ,\I Crnw-Hill Canada, Toronto,
197 J. . ' I 0 .00.

This is not lh fi rst hook th auth r ha~
writt 11 in the fie ld of geriatri · anesthesia .
Once mor he brings lo us his cl eep know! dg
of the Id rly pati nt, with sp cine e mphasb
on the basi · pathophysiologic chm1g
that
Ot' ur with th
age.in pro ·ess. He has mastered th difficult task of writing a brief,
easil)' read book, wJ1ich is well documented

i
K

e
e

nnd contains th e most urrcnL informat ion 0 11
this particular aspect o f anesthesia .
If compared to th monob•raph " ri a tric
nesthesia" publi.~hed in Hl55, the form and
:1rrange111 nl of this book js almost id ntical.
T his prescrv s th , origin ii purpose of the
book which is dire· ted to those who are 1101
lnmilinr with th in 1nagc111 ' llt of th e ttgcd
pali •nt.
1'or those who are in volved regular! in
g riatric anesthesia, this book rem ains a good
general sou r ·e of information and is ve rv r freshing. rt is recon un en<led for ge11 °rnl ' hospit al libraries t1t th fair price of $10.00.
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B NNELL'S SUHCERY OJ~ THE HA ' D. 5th l'd.
Hcviscd by J oseph H . Bu>' ·s. 727 pt>. lllust.
J. B. Li1>1>in<.-ott Company, Phil11dclphi11; J. n.
ippincott Com1>tmy
Canada Ltd., Toronto,
1970. '35.75.
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Once a~ni n in Dr. Jos ph Boy .~• r vised fifth
ec.lilion of '' Bu11nell's Surg ry or Iii J la nd".
we find •xt nded x e lle11c ,, The II w lexl
hns a mo r compa ' l nature with ven hell r
orgn11 izatio11 tha n th last edition . Many additio, a l clinicn l and ha lf-ton
photogra phs
further 111odify the subj c t 11 alt 1·. l\losl of the
previous colour photos J1 ave h een d le ted .
This n w ed ition , as a lwa ys, ,. rn ains a 11111st
in <•very surgeon's library nnd hop full y, n
fr qu •nt r fer nee i11 his hand!
CAMPBELL' OPEHATIVE OHTHOPAEDTC .
2 vols. 5th eel. Edit ed by A. H. Crenshaw.
20<14 Ill>, nnd indexes. lllust . Thl' C. \I. Mosb ,
Company, SI. Loui ·, 1971 . $83.50,

Th . fifth clition of "Campbe ll's Op rntive
Orthopaedics" also marks th go lde n annivers~1y of th foundin~ o f th , Campbell linic.
!his ed ition maintains the high . standards of
ll~ pr d ee ssors • th "E ncyc loped ia J~dtla11ic-:1'' of orthopedic surg ry: In th e ight
)'ears that s parnl e this c· litio11 from the last,
!llany new surgical ted111 iq ues ha v b n
introdul'cd and most of lh . are incl11decl:1 uniq ue achievemen t when 011 considers the
111 vitah le d lay be twc n the tim e th m :111usc1·ipt is "put lo bed" a11d the moment th ·
Vol~n cs ar final! published .
1 he formal nnd clrnp t r l1endings o f th is

dition • re identi al to the previ us on . The
r ader familiar with " ampbell's" will 110 1 o n!
f e l al home hut also will lie pleas d b the
addition of iniprov d ill11slrations uncl . om "
new opern tiv
t chnology-notabl
in the
fields o l partial am putations of th e hand, immediate posloperotiv fitting of prosth ses,
anterior approa hes lo th spin al column for
various disor ers, spinal d)'staphism a nd, last
hut not I as t, instnun ntatio n for scoliosis. In
regard to .~colir,sis, 110 m 11tion is made of
Dw)'er's techniq ue fot· th • correction ()f spinal
curvature doubtless be,·aus • tbe technique was
p11hlished too recently to be included.
nut despite these improv ments t·here m·e
some glaring omissions. Sp c ificall)', H is frus trating to find that tota l rcplac menL arthroplas t)' of th e hip is liismi.~s d as an xp rimen ta l proc dme. when ii ha n hicvecl such
world-wid succ ss over sev ra l year ·. This
i. particul. rly so when the hri f (.'Ollllll nt
about it (one-half page) fo llows no less than
42 pages on mould arthroph1sty, a procedur
that many consid r of rath r 1· slric ted va lu .
As the s ction on mould arlhroplnsty was
writte1 by a gue l editor, wh )' was an
au thoril.y on total liip r 11lacement not invil cl
lo be a g11es t dito r too? Similarly, in th e section 0 11 kn ee 11rthroplasty it is astonishing to
find that the on ly t chnique d escrib t1 is
fasdal arthroplas ly. Smel)' most l't!lllr s ha ve
replaced this with the much m re us ful Ma •
l.11 tosh tibial-plateau prosthesis? furth rmor ,
ther is no men tion whatsoe ' r of Swa nson's
Silnslic joint replacements.
I11 th sections on nerv i11jLn"ies, no m ntion is made of fascicular suture; 011 • questions th , value o f th section on joint den rvntion, u procedu re most c ntre. have found lo
be of little permanent valu e.
Finally, th book s11ffcrs from the in clusion
of too much d etailed description of historica ll y important but 110w oulmodec.1 procedures.
For exmnpl , does anyone nowadays use
lbe 's or llibh' t chniques f r spina l fusio11
as they were clescrih d in 19 l l ? Perhaps th
d itots sho11ld ha ve pr faced ea h sccti n with
11 histori('n) paragraph i11 whi h aha 11done<l but
n vertheless d assic prOC'etl ures are summarized
(, ith ref r ' nee.~ lo th litern tur ) rn thc r than
giving d tail <l de.~c:riptions of th e opera ti vp
t c hniqu · . 1n makinv; these critici sms, one
r cognizes with respect the enormous task the
editor.~ undertake in sift ing \ hat is II w u11d
, alunble :111d discarding what is history.
Despit Hs astronornienl p rice {$83 ..50 ) tlw
11 wl)' tra ined ort hopedic surg on or resid 111
ca nnot nfford lo do without this 11 ew edition
of "C(1111pb ll's". However, those who ow11 th
our th dHio11 might compare it ca r rt11l)1 with
th 11ew firth •<lilio11 hc for · d<- ·id ing to r place it.
(C<>11l/1111cd
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(Continued from Adv. page 27)

The third edition of this well-known book
maintains the extremely high standard set by
previous editions. This edition incorporates
much new material and many sections have
been entirely rewritten. This has been done
without deleting much of the original content
of the book. A review of the expanding field
of experimental oncogenesis of the nervous
system has been included. The contributions
of electron microscopy have been incorporated.
The text also includes a chapter on tissue
culture of tumours of the nervous system by
Professor C. E. Lumsden. The entire text is
completely up to date. The book maintains its
place as the leading exposition on the path
ology of nervous system tumours.
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TEXTBOOK OF DISORDERS AND INJURIES
OF THE M USCULOSKELETAL SYSTEM. An [
Introduction to Orthopaedics, Rheumatology,
Metabolic Bone Disease, Rehabilitation and
Fractures. Robert Bruce Salter. 551 pp. Illust.
The Williams & Wilkins Company, Baltimore;
Burns & MacEachern Limited, Toronto, 1970.
$21.75.

This book is clearly written and well illus
trated. It is, as the author states, a textbook
written for undergraduate students. The organ
ization is excellent and gives a good introduc
tion to the subjects in the text. This is an (
excellent book for the undergraduate medical
student who desires a short description of |
virtually all orthopedic disorders and most
common injuries. It will be difficult, however,
for the undergraduate to read and absorb all
the material during his rotation on the ortho
pedic service as a clinical clerk. It is written
in a manner that would be easily understood
in the early years of a medical course and the
book would be satisfactory to retain for later
use in a general practice office.
For postgraduate students this reviewer
would recommend the book highly as an intro
duction to a course of studies in the musculo
skeletal system because it is a well-organized
relatively complete introduction to the entire
field. Of particular value is the classification
of large subjects. Because the descriptions of
the disease entities for the most part are brief,
it is inadequate as a resident’s reference book
for details of a disorder or in the management
of injuries in detail. The author, however, has
stated this to be the case and has not intended
it to be a reference book.
This textbook is recommended to medical
undergraduate students and. in addition, to
any student in the field of musculoskeletal
medicine and surgery. Those engaged in the
teaching of orthopedics would be well ad
vised to purchase the book and read it for it
should help them to be better teachers.
Finally, the book is good value for the price
of $21.75.
(Continued on Adv. page 30)
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SURFAK
Surfak is a safe, effective fecal
softener which prevents the fo r
mation of hard, dry stools thus
reducing pain and discomfort,
undue straining and irritation.
Surfak is not a laxative. . . it
acts solely to permit normal bowel
function by preventing the fo r
mation of hard, dry stools.
Com position: Each capsule con
tains 50 mg. or 240 mg. of dioctyl
calcium sulfosuccinate. Indica
tions; Prevention and treatment
of constipation, especially in he
morrhoids, anal fissures, geriatrics,
pediatrics, immobilized patients,
pregnancy, following anorectal
surgery, ulcerative colitis, divert
iculitis, and to avert straining after
abdominal surgery, in cardiac
patients and hypertensive patients.
Contraindications: None known.
Precautions; None known. Ad
verse effects: Mild, transitory
cramping pains may rarely occur.
Dosage: Usual adult dose is 240
mg. daily; .children and adults with
minimal needs, 50 to 1 50 mg. daily.
Supply: Red, soft gelatin 240 mg.
capsules in bottles of 100; orange,
soft gelatin 50 mg. capsules in
bottles of 100.
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Books R eceived
Books are acknowledged as received, but
in some cases reviews will also be made
in later issues.
Atlas of Ear Surgery. 2nd ed. William H.
Saunders and Michael M. Paparella. 390 pp.
Illust. The C. V. Mosby Company, St. Louis,
1971. $33.60.
Chest Injuries. Physiologic Principles and Emer
gency Management. Emil A. Naclerio. 383 pp.
Illust. Grune & Stratton, Inc., New York, 19/1.
$28.50.
Congenital Absence of the Ear. Eric W. Peet.
39 pp. Illust. E. & S. Livingstone Ltd., Edin
burgh; Longman Canada Limited, Toronto, 1971.
$7.25.
Fettstoffwechselstorungen. Ihre Erkennung und
Behandlung. Edited by Gotthard Schettler. 184
pp. Illust. Intercontinental Medical Book Corp.,
New York; Georg Thieme Verlag, Stuttgart, 1971.
DM 24,00. $7.00 (approx.). Paperbound.
Gastrointestinal Motility. International Symposion on Motility of the GI-Tract, Erlangen,
July 15th and 16th, 1969. Edited by Ludwig
Demling and Rudolf Ottenjann. Georg Thieme
Verlag, Stuttgart; Academic Press Inc., New York,
1971. $7.50.
Kurze HNO-Operationslehre fur Arzte und
Studierende. Band 1: Operative Eingriffe an Nase,
Nasen- und Mundrachen, Hypopharynx, Kehlkopf
und ausserem Hals. Gerhard Theissing. 308 pp.
Illust. Intercontinental Medical Book Corp., New
York; Georg Thieme Verlag, Stuttgart, 1971. DM
49,00. $14.30 (approx.). Paperbound.
Lungenmykosen. Vortrage der Fruhjahrstagung
der Rheinisch-Westfalisehen Vereinigung fiir
Tuberkulose- und Lungenheilkunde am 14. Marz
1970 in Diisseldorf. Edited by Hans Bartsch. 64
pp. Illust. Intercontinental Medical Book Corp.,
New York; George Thieme Verlag, Stuttgart,
1971. DM 22,00. $6.40 (approx.). Paperbound.
Nephron Failure. Conservation. Substitution.
Replacement. John B. Dossetor and M. Henry
Gault. 303 pp. Illust. Charles C Thomas, Pub
lisher, Springfield, 111.; McGraw-Hill Company of
Canada, Toronto, 1971. $23.75.
Orthopadische Therapie. George Chapchal and
Detlev Waigand. 533 pp. Illust. Intercontinental
Medical Book Corp., New York; Georg Thieme
Verlag, Stuttgart, 1971. DM 98,00. $28.65 (ap
prox.).
Peptic Ulcer. Edited by Carl J. Pfeiffer. 356
pp. Illust. Munksgaard, Copenhagen, 1971. Dan.
Kr. 50.00. $7.20 (approx.). Paperbound.
Plastic Surgery in Infancy and Childhood.
Edited by John Clark Mustarde. 581 pp. Illust.
E. & S. Livingstone, Ltd., Edinburgh; Longman
Canada Limited, Toronto, 1971. $25.25.
Review of Medical Physiology. 5th ed. William
F. Ganong. 573 pp. Illust. Lange Medical Pub
lications, Los Altos, California, 1971. $8.50.
Paperbound.

Rontgendiagnostik des Schiidels. W. Loepp and
R. Lorenz. 2nd ed. Edited by R. Lorenz. 397 pp.
Illust. Intercontinental Medical Book Corp., New
York; Georg Thieme Verlag, Stuttgart, 1971. DM
158,00. $45.50 (approx.).
The Structure and Support of Contemporary
Residency Programs in Surgery. Transactions of
the 13th Annual Meeting of the Allen O. Whipple
Surgical Society. Edited by Harold G. Barker.
290 pp. Charles C Thomas, Publisher, Springfield,
111.; McGraw-Hill Company of Canada, Toronto,
1971. $15.00.
The Surgical Control of Behavior. A Sym
posium. Edited by Arthur Winter. 90 pp. Illust.
Charles C Thomas, Publisher, Springfield, 111.;
McGraw-Hill Company of Canada, Toronto, 1971.
$9.50.
Transplantation Today. Proceedings of the Third
International Congress of the Transplantation
Society, September 7-11, 1970, The Hague, The
Netherlands. Edited by Hans Balner, D. W. van
Bekkurn and Felix T. Rapaport. 978 pp. Illust.
Grune & Stratton, Inc., New York; Longman
Canada Limited, Toronto, 1971. $28.75.

SIMULTANEOUS PROSTATECTOMY AND IN
GUINAL HERNIORRAPHY. Sidney R. Wein
berg, Albert Kovetz and Stephen M. Lazarus.
51 pp. Illust. Charles C Thomas, Publisher,
Springfield, 111.; McGraw-Hill Company of
Canada, Toronto, 1971. $8.00.

This short monograph is written by a urologist
for urologists. It will make little impact on the
general surgeon because it is most unlikely
that he will be persuaded to refer his patients
to a urological colleague for the combined
procedure of prostatectomy and inguinal
herniorrhaphy, nor will combine with him in
a procedure in which he performs the hernior
rhaphy. The surgeon will be largely influenced
in these opinions by the recurrence rate of
12% quoted by the authors in the combined
procedure. Equally he is unlikely to agree
with the figures quoted by the authors for the
recurrence rates of both indirect and direct
inguinal herniorrhaphy alone. In both groups
much lower figures are now regarded as ac
ceptable. Nor is he likely to agree that separat
ing the operations carries with it increased
operative risks sufficient to warrant adoption
of the simultaneous combined procedure. On
the contrary, after a study of the results, the
general surgeon is more likely to persuade his
urological colleague that he is better advised
to confine his activities to the prostatectomy
alone.
These impressions are confirmed by the gen
eral balance of the book. It is strongly
orientated to the problems of prostatectomy
while the section dealing with inguinal herni
orrhaphy is indifferent.

